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Abstract

MyTH4 and FERM Have Overlapping and Distinct
Roles in the Function of Myo1, a Class XIV Myosin in
Tetrahymena thermophila
By
Michael Gotesman

Adviser: Dr. Ray H. Gavin

MyTH4 and FERM are conserved tail domains in myosin classes VII, X, XII,
XIV, XV and in MyoG. Myo1, a class XIV myosin in Tetrahymena thermophila,
contains MyTH4 and FERM. Previous studies have shown that Myo1 localizes to
phagosomes, the cytoskeleton, and the macronucleus, and that phagosome trafficking and
division of the macronucleus are affected in a MYO1 knockout. To investigate the roles
for MyTH4 and FERM in the function of Myo1, GFP-tagged MyTH4, FERM, and
truncated FERM were separately overexpressed in Tetrahymena. Actin antibody
coprecipitated tubulin, GFP-MyTH4, and GFP-FERM. GFP-MyTH4 and GFP-FERM
cosedimented with either exogenous microtubules or exogenous F-actin. GFP-MyTH4
iii

localized to phagosomes and colocalized with antitubulin to intranuclear microtubules.
Overexpression of GFP-MyTH4 inhibited the organization of the parallel array of
intranuclear microtubules that form prior to division of the macronucleus. Cells that
failed to form the parallel array of microtubules did not advance in nuclear division.
Overexpression of GFP-MyTH4 did not affect phagosome recycling. Overexpressed
GFP-FERM localized to phagosomes, cytoskeleton, and intranuclear puncta and did not
affect division of the macronucleus. Overexpression of truncated GFP-FERM did not
localize to the cytoskeleton or nucleus and led to the accumulation of phagosomes at the
membrane recycling site in the posterior of the cell. It is unlikely that the overexpression
phenotypes are nonspecific effects of GFP. Localization of GFP-fusions is consistent
with the localization of full-length Myo1, and overexpression phenotypes mimic the
knockout phenotype. Furthermore, GFP-MyTH4 from Myo9, another Tetrahymena
myosin, did not localize in Tetrahymena thermophila. We conclude that MyTH4 and
FERM have overlapping roles as indicated by the interaction with actin and tubulin.
However, MyTH4 and FERM appear to have distinct roles in the function of Myo1.
MyTH4 affects the organization of microtubules involved in macronuclear division,
whereas FERM affects recycling of phagosomes and is required for localization to the
cytoskeleton.
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Chapter 1
1.1

Myosin Structure and Function
Discovery of Myosin

Myosin was first isolated and described by Willi Kuhne in 1864, as a “proteid”
found in the extracts of frog leg muscles and was later isolated from rabbits (Halliburton,
1887). The role of myosin in muscle contraction led to several very important
observations. Myosin was shown to be an ATPase (Engelhardt and Lyubimowa, 1939).
Straub isolated the activator of myosin and named it actin for its ability to activate the
ATPase catalytic ability of myosin (Straub, 1942; Straub, 1943). Magnesium ion was also
shown to be involved in myosin ATPase activity by Banga and et al., (Banga, 1942;
Banga and Szent-Gyorgi, 1942). The sliding filament model for muscle contraction
explained the role of myosin and actin in muscle contraction (Huxley, 1954). Ultimately,
the discovery of a non-conventional or non-filament forming myosin in Acanthamoeba
castellani (Pollard and Korn, 1973) ushered in the study of non-conventional myosins.
1.2

General Organization of Myosins

The super-family of myosin consists of ~35 classes, with ~2,300 members
grouped according to homology in their motor domains (reviews, Berg et al., 2001;
Williams and Gavin, 2005; Richards and Cavalier-Smith, 2005; Foth et al., 2006;
Ordronitz and Kollmar, 2007). All myosins are actin-dependent molecular motors that
utilize the power released in the hydrolysis of ATP to translocate along actin “tracks”
(Lymn and Taylor, 1971) in a process known as acto-myosin mediated translocation.
Myosins are usually composed of two domains. The N-terminus or motor domain is a
highly conserved region among myosins. It has the site for ATP hydrolysis and a site for
actin binding, (see review, Gavin, 2001). The C-terminus or tail domain varies greatly
1

among myosins. The conventional or filament forming myosins are categorized as class
II myosins. The unconventional or non-filament forming myosins make up the other ~34
super-classes (Richards and Cavalier-Smith, 2005). Class II myosins have long segments
of coiled-coil (CC) regions in their tails. This allows them to form thick filaments as seen
in muscle-cells. Because conventional myosins dimerize through their CC domain, many
class II myosins can work together to exert a large amount of force as in muscle flexing.
Non-filamentous forming myosins (Pollard and Korn, 1973) usually have truncated tails.
Unconventional myosins have several other types of domains in their tails that allow
myosins to function in specialized cellular activities, such as intracellular trafficking
(Durbach et al., 1996, Barsoum and King-Smith, 2007), intranuclear trafficking (Chuang
et al., 2006), and to function in mammalian motile and sensory cilia (Wolfrum et al.,
1998).
1.3

What are the Different Myosin Homology Tail Domains?

It is presumed that the differences in the myosin tail domain allow myosins to be
utilized in a great diversity of function. Class I myosins localize to the leading edge of the
lamellipodial projections of migrating Dictyostelium amoeba (Fukui, 1989) and to

Acanthamoeba lipids (Adams and Pollard, 1989) that are transported in vitro along
actin tracks (Adams and Pollard, 1986). Acanthamoeba class I myosins (Pollenz,
1992) contain three distinct myosin tail domains termed tail homology (TH) regions TH1, TH-2 and TH-3 (Lee et al., 1999). The TH-1 domain is basic and binds lipids
(Doberstein and Pollard, 1992); the TH-2 region is Gly/Pro/Ala-rich (GPA) and binds
actin (Lee et al., 1999; Yu and Bement 2007); and the TH-3 region has a 55-residue src
homology-3 domain that binds to the PXXP region of the Acan125 protein (Xu et al.,
2

1997). MyTH4 (myosin-tail-homology-4) (Chen et al., 1996) domain is often coupled
with band 4.1-ezrin-radixin-moesin (FERM) as in myosins VII, X, XV (Bohil et al.,
2006), XIV (review, Williams and Gavin, 2005), and in the N-terminus of KCBP
(kinesin-like-calmodulin-binding protein) (reviews, Berg et al., 2001; Richards and
Cavalier-Smith, 2005).
1.4

MyTH4 Domain

MyTH4 is usually adjacent to a FERM domain, although two of the Tetrahymena
myosins contain either a MyTH4 or FERM but not both (Williams and Gavin, 2005), and
in class IV and class XXIII myosins, MyTH4 exists without FERM (Coluccio, 2008).
MyTH4 in a kinesin exists independent of FERM (Narasimhulu and Reddy, 1998), and
FERM exists independent of MyTH4 in a kinesin-like protein (Awan et al., 2004) and in
ERM (ezrin, radixin, moesin) family proteins (Reviewed by Bretscher et al., 2002).
Distinct functions for the two domains have generally not been established, and
MyTH4/FERM is often described as a single functional complex with actin and tubulinbased roles. Relatively few studies focus on the role of one domain independent of the
other. MyTH4 in a plant kinesin directly binds to microtubules (Narasimhulu and Reddy,
1998), but in Myosin X, both MyTH4 and FERM are required for maximal microtubule
association (Weber et al., 2004).
1.5

FERM Domain

The founding member of the FERM superfamily, protein 4.1-band, was first
recognized as an isolate that acted in the linking of the erythrocyte membrane proteins
with spectrin and actin. Protein 4.1-band has been isolated from many other tissues and
organs such as the bone marrow, cerebellum, lungs, testes and thymus (Conboy et al.,
3

1986; review, Diakowski, 2006). Members of the FERM superfamily now include:
protein 4.1 band, talin, merlin, protein-tyrosine-phosphatase (PTPH), novel band 4.1-like4 (NBL4), and ezrin-radixin-moesin (ERM). (review, Diakowski, 2006). The x-ray
crystallography of highly conserved ERM proteins, human moesin, shows that the FERM
domain forms a compact clover-leaf shaped structure made of three different lobes (1-3)
each showing similarity to known structures: ubiquitin, acyl-CoA-binding protein, and
the pleckstrin-homology (PH)/ phosphotyrosine-binding (PTB)/ enabled-VASPhomology-1 (EVH1) domain, respectively (Pearson, et al, 2000). Similarly, the x-ray
crystallography of mouse merlin revealed that the FERM domain also forms a cloverleaf
structure that consists of the previously described lobes (Shimizu et al., 2002).
Several proteins contain a FERM (band 4.1-ezrin-radixin-moesin homology) domain
that interacts with the actin and microtubule cytoskeleton (Bretscher et al. 1997; Chishti
et al., 1998; Mattagajasingh, 2000; Muranen et al., 2007; Yan, 2001). ERM family
proteins consist of an N-terminal FERM domain, an alpha helical domain, and a Cterminal ERM association domain (C-ERMAD) (Reviewed by Bretscher et al., 2002).
Each of the three domains contains one or more binding motifs for intramolecular or
intermolecular associations (Hamada et al., 2000; Li et al., 2006; Pearson et al., 2000).
Structural studies of the FERM domain reveal three sub-domains (F1, F2, F3 or A, B, C)
that are potential binding surfaces for proteins, peptides or phospholipids (Pearson et al.,
2000; Kitano et al., 2006). In vitro, FERM binds to actin (Lee et al., 2004), tubulin
(Muranen et al., 2007), membrane proteins (Yonemura et al, 1998), and phospholipids
(Niggli et al., 1995; Hamada et al., 2000). Studies of the interaction between adhesion
proteins and ERM proteins reveal that in vivo, ERM proteins exist in either an active or
4

inactive form. In the inactive or masked state, FERM binds intra-molecularly to the CERMAD, an interaction that partially blocks the FERM surface effectively masking
binding sites within FERM (Pearson et al., 2000). Unmasking or activation of ERM
proteins involves phosphorylation of the tail domain and lipid binding, which release
FERM from its intra-molecular binding and unmask binding sites (Hamada et al., 2000;
Pearson et al., 2000). Crystal structures of radixin show that FERM bound to the
adhesion molecule ICAM-2 (Inter-Cellular Adhesion Molecule) recognizes the CERMAD sequence RxxTYxVxxA (Hamada et al., 2003). Crystal structures of moesin
reveal another binding site within FERM. Binding of moesin to EBP50 (ezrin binding
protein) is prevented in dormant moesin in which FERM binds to a conserved 11-aa
(TKQRIDEFEAL) motif in the C-ERMAD. In the active state, moesin FERM binds to
the same 11-aa motif in EBP50 (Finnerty et al., 2004). Crystal structure of dimerized
radixin FERM domains reveals that the C-terminal conserved motif (KxxTIxVxxM) in
one FERM molecule binds sub-domain C within the other FERM molecule (Kitano et al.,
2006). Studies of liposomal membranes demonstrate that ERM family proteins (such as
talin, 4.1 and ezrin) destabilize membranes and induce large holes in the membrane
bilayer (Saitoh et al., 1998; Takeda et al., 2006). Membrane hole formation preferentially
occurs with neutral and acidic phospholipids, is reversible, and involves both FERM and
the C-terminus of ERM family proteins (Saitoh et al., 1998; Takeda et al., 2006).
One of the 4.1 isoforms termed 4.1R is a mitotic microtubule associated protein and
has been shown to partially co-localize with tubulin (Huang et al., 2004). The 30-kDa Nterminus membrane binding domain of 4.1R, termed FERM, is involved in
intramolecular interactions with other members of FERM (Pérez-Ferreiro, 2006). Using a
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yeast two-hybrid assay, two isoforms (~135 and ~150 kDa) of 4.1R have been shown to
interact with actin at tight junctions (Mattagajasingh et al., 2000). Ezrin and its homologs,
radixin, moesin, and merlin are concentrated in microvilli and can interact with F-actin to
link microfilaments to membrane (Bretscher et al., 1997). Merlin binds to microtubules
and actin through its FERM domain (Xu and Gutman, 1998; Taru et al., 2007).
TalinA is another of the FERM proteins that has the FERM N-terminus extension, it
has been shown to link the actin cytoskeleton to beta-3-integrin cytoplasmic domains
(Yan et al., 2001) and to interact with a previously uncharacterized region of Myosin VII
in Dictyostelium (Tuxworth et al., 2005). The actin-binding sequence in talin FERM has
been elucidated in humans, mouse, Dictyostelium and other model organisms (Lee et al.,
2004).
1.6

What is Known About the Function of MyTH4/ FERM Coupling in
Myosins?

The precise function of MyTH4/FERM coupling is poorly understood, but it is
believed to act as a “cross bridge” for microtubule and microfilament interaction either
through direct contact or the recruitment of protein partners that can interact with both
cytoskeletal proteins (Reddy and Reddy, 1999). A yeast two-hybrid assay showed that
Shroom2, an F-actin binding protein, binds to the FERM domain of myosin VIIa
(Etournay, 2007).
Human myosin VII contains MyTH4/FERM coupled twice and mutations to this
myosin causes Usher Syndrome as well as deafness (Wolfrum et al., 1998). Myosin VIIA
is also localized to mammalian cochlear stereocilia (Hasson et al., 1997) and is necessary
for Drosophila auditory organ development (Todi et al., 2008). A MyTH7 (myosin-tail6

homology-7) domain has been identified as a conserved region in the third lobe of the
cloverleaf structure in both FERM domains of myosin VII (Kiehart et al., 2004) and
binds actin (Yang et al. 2009).
Myosin X is required for nuclear anchoring and spindle assembly in Xenopus
oocytes (Weber et al., 2004). Myosin X binds to microtubules through its MyTH4/FERM
domain (Weber et al., 2004). The MyTH4/FERM coupled domain in class X myosin also
participates in the formation of dorsal filopedia in Hela Cells (Bohil et al., 2006). The
FERM domain of myosin X can reorganize F-actin in COS-1 cells (Yonezawa, 2003).
The tail region of myosin X post IQ recognizes fascin bundled actin-filaments (Nagy and
Rock, 2010).
Mutations to myosin XVa cause deafness in humans and mice, and shakers
syndrome in mice. Myosin XVa localizes to the tips of cochlear and vestibular hair cell
stereocilia in mice and is necessary for the proper formation of staircase-like arrangement
of stereocilia in mature hair bundles (Belyantseva et al., 2003). Myosin XVa is required
for programmed stereocilia elongation (Belyantseva et al., 2005). Sisyphus, the
Drosophila myosin XV homolog, contains an additional MyTH4 in conjunction with a
MyTH4/FERM coupled domain that is required for trafficking of alpha-tubulin and
tubulin-associated proteins such as Katanin-60, EB1, and Milton (Liu et al., 2008). RNAi
knockdown of sisyphus disrupts the organization of both the actin and microtubule
cytoskeletal (Liu et al., 2008). Although Myosin V does not contain a MyTH4/FERM
coupling, immunofluorescence staining with antibodies against myosin Va revealed
localization to microtubule rich regions such as the microtubule organizing center and to
the mitotic asters, spindle, and the mid-body of dividing cells in a variety of cell types,
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including primary and immortal mouse melanocytes and fibroblasts, Hela cells, and Cos
cells (Wu et al., 1998). MAX-1 is a neuronal guidance protein, conserved among
drosophila and humans. MAX-1 has a MyTH4/FERM domain and the FERM domain is
required for the proper localization of MAX-1 (Huang et al., 2002).
1.7

MyTH4 and FERM Domains in Kinesins

The MyTH4 domain in the C-terminus of an Arabidopsis KCBP binds to
microtubules (Reddy and Reddy, 1999; Narasimhulu, 1998). A kinesin II kinesin-likeprotein (Klps), kin5, in T. thermophila has a FERM domain in its tail and localizes to
components of the intraflagellar transport system (Awan et al., 2004). The authors
speculate that the Kin5 FERM interacts with membrane proteins (Awan et al., 2004).
1.8

Myosin in the Nucleus?

Initial fluorescence recovery after photobleach (FRAP) experiments suggested
that the role for actin and myosin in nuclear transport was in controlling the pore size of
the nuclear pore complex (Schindler and Jiang, 1986). Class I myosins target the nucleus
by an N-terminus extension (Pestic-Dragovich et al., 2000), localize to active nucleoli in
human cells, interact with RNA polymerase I complex (Percipalle et al., 2006), and play
a role in transcription activation with actin (Ye et al., 2010). Nuclear Myosin I localizes
to dense fibrillar component sites of active Pol I transcription and rDNA processing in
contrast to nuclear actin which predominately reside in Fibrillar Centers, sites of of Pol I
and transcription storage. (Philimonenko et al., 2010, and reviews within). One of the
three class V myosin paralogs, Myo5a, localizes to active DNA transcriptional regions in
the nucleus (Pranchevicius et al., 2008), termed speckles, and has been implicated in
trafficking mRNA from the nucleus to cytosolic destinations (Salerno et al., 2008). The
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globular tail of myosin Vb fused to a GFP-tag localized to active transcriptional regions
of the nucleus, termed nucleoli, in Hela cells (Lindsay and McCaffrey, 2009).
Accordingly, myosin Vb has been shown to interact with beta-actin and RNA polymerase
I by coimmunoprecipitation studies (Lindsay and McCaffrey, 2009). A class V myosin in
Saccharomyces cervisiae, Myo4p is involved in transporting mRNA of ASH1 in cell
determination (Chartland and et al., 2002). The Myo16a tail and may target the nucleolus
by ankryin repeat domains and colocalizes with actin, and cyclin A in the nucleus
(Cameron et al., 2007).
1.9

Myosin Function in Regulating Actin Dynamics

Actin dynamics can be used by cells for intracellular trafficking (Basciano and
King-Smith, 2002; McNeil et al., 2004). Filopodia and lamellipodia are cytoplasmic
protrusions that contain actin bundles. Myosin-X (Myo10) is ubiquitously expressed in
human cells, and localizes at sites of dynamic actin and actin-rich ruffles at the tips of
lamellipodia in an actin-independent manner (Berg et al., 2000). Over-expression of
GFP-Myo10 in mouse intraembryonic endothelial cells (MECs) increases the number of
filopodial extensions (Pi et al., 2007). The tail region of myosin-X, that is C-terminal to
the IQ domain, recognizes fascin bundled actin-filaments (Nagy and Rock, 2010). Myo10
colocalizes with Mena/VASP and interacts with the Mena/VASP complex to promote
actin growth at filopodia tips in Hela cells (Tokou and Ikebe, 2004). Myo10 initiates
filopodia formation as a dimerized motor truncated for the MyTH4/FERM region in
COS7 and NIH3T3 cells (Tokou et al, 2007). Interestingly, the MyTH4/FERM domain of
Myo10 binds to NPXY in integrins (Zhang et al., 2004).

9

1.10

Interaction among Microtubules and Actin-filaments

Reviews for complementary (Langford, 1995) and synergistic (Gavin, 1997;
Gavin, 1999) roles for microtubule and filamentous actin have elucidated but have not
fully explained the mechanism of the interactions between the microtubule and f-actin
cytoskeletal polymers. Viscometry experiments in 1978 first revealed actin filamentmicrotubule interaction mediated by microtubule-associated-proteins (MAPs) (Griffith
and Pollard, 1978). Bovine brain derived microtubule-associated-proteins-2 (MAP-2) cosediments Rabbit psoas (psoas is muscle from the abdomen) actin in a ratio of ~1
molecule of MAP-2 to 28 molecules of actin (Sattilaro et al., 1981). Affinity
chromatography and electron microscopy studies have shown that the tubulin binding
sequences of tau (Lewis et al., 1988), which is similar to the MAP-2 tubulin binding
sequence (Lewis et al., 1988; Doll et al., 1993), binds actin (Correas, et al., 1990).
Microscopy and co-sedimentation assays have shown that the previously described actinbinding domains in FERM bind tubulin in ezrin and its homolog in merlin (Muranen et
al., 2007). The actin based molecular motor, myosin-Va, has been shown by microscopy
and co-sedimentation assays to mechanochemically couple MTs to actin filaments (Cao
et al., 2004).

10

Chapter 2
2.1

Tetrahymena thermophila
Culture and Feeding

Tetrahymena thermophila, formerly known as T. pyriformis variety 1 or syngen 1
(Nanney and McCoy, 1976), is a free living, heterotrophic, ciliated protist that has been
adopted as a model organism for the study of many cellular processes. The oral apparatus
(OA) of Tetrahymena is a large cortical feeding structure, consisting of ciliated basal
bodies (Gavin, 1980). Tubulin (Williams, 1986; Williams and Honts, 1987), actin (Hirino
et al., 1987; Hoey and Gavin, 1992; Hosein et al., 2005), myosin (Garcés et al., 1995),
and centrin (Guerra et al., 2003) localize to the OA of T. thermophila. Phagosomes form
in the OA, at the base of the buccal cavity (Kitajima and Thompson, 1977). Cytochalasin
B, is an inhibitor of actin polymerization and has been shown to disrupt phagocytosis
process in Tetrahymena, including the area around the OA (Hoffmann et al., 1974).
Tetrahymena can grow in the absence of phagocytosis (Rasmussen and Orias, 1975) by
utilizing clathrin-dependent endocytosis (Elde et al., 2005). Endocytosis occurs at
membrane sites adjacent to cilia, including cilia that compose the oral apparatus (Nillson
and Van Deurs, 1983). Phagosomes and endosomes fuse with lysosomes (Kitajima and
Thompson, 1977). Of the 73 putative Tetrahymena phagosome proteins identified, 28
have been implicated in the phagocytosis process in other organisms (Jacobs et al., 2006).
After food is processed in phagosomes, unwanted material is released back to the
environment and the surrounding membrane is recycled at the cytoproct, a membrane
structure located in the posterior of the cell (Kitajima and Thompson, 1977; Allen and
Wolf, 1979). Actin localizes to the cytoproct and treatment of Tetrahymena with
Latrunculin B disturbs the shape of the cytoproct, however treatment with Nacodozole, a
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microtubule depolymerizing agent, inhibits the egestion of food vacuoles through the
cytoproct (Sugita et al., 2009)
2.2

Nucleus

Tetrahymena thermophila exhibits nuclear dimorphism; it has a somatic
macronucleus (MAC) and a germline micronucleus (MIC). The MAC contains ~45
copies of each chromosome and is active during vegetative growth. The MIC has five
chromosomes and is only active during sexual reproduction. During vegetative growth
the MAC elongates and constricts, and its contents are divided into two approximately
equal subnuclei (Orias, 1991), a process known as amitosis. Amitosis involves the
macronuclear microtubules (Williams and Williams, 1976), without much chromosomal
condensation in the MAC (Flickinger, 1965). During cytokinesis, cytoplasmic and
macronuclear microtubules respectively organize in the cytoplasm and the MAC to aid in
macronuclear division (Numata et al., 1999). The Tetrahymena macronucleus genome
was sequenced (Eisen et al., 2006) and has been open to the public as of 2/2/04 at the
Tetrahymena Genome Database (ciliate.org). The micronucleus divides mitotically, and
two G-DNA-binding proteins, TGP1 and TGP2, aid in micronuclear division (Lu and
Henderson, 2000).
2.3

Conjugation

Tetrahymena thermophila is sexually active, having 7 different mating types
controlled by the mat locus, which is adjacent to the ribosomal RNA gene (Bleyman,
1992). A zygotic nucleus forms through fusion of a pronucleus from each conjugant. The
zygotic nucleus develops into two new genetically matched macronuclei and micronuclei,
and the pre-existing macronucleus is eliminated. The first cell division of exconjugants
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produces cells with a genetically matched macronucleus and micronucleus.
2.4

Overexpression Vector for Tetrahymena

Ribosomal DNA (rDNA) based vectors (Tondravi and Yao, 1986; Yao, 1986) are
used to transform T. Tetrahymena (Gaertig et al., 1994) by inducing the amplification of
engineered rDNA constructs. pIGF-1, created by M.C. Yao, is commonly used for the
over-expression of genes in Tetrahymena. The pIGF-1 cloning site consists of an MTT1
promoter (Shang et al., 2002) that is inducible by ionic cadmium, a GFP gene, and a
transcriptional stop sequence. The vector also contains Tetrahymena and bacterial origins
of replication and genes for neomycin and ampicillin resistance. Genes of interest are
cloned 3’ to the GFP site in pIGF-1 and therefore are expressed with an N-terminus GFP
tag. Biolistic bombardment (Cassidy-Hanley et al., 1997; Bruns and Cassidy-Hanley,
2000) is used to insert the vector into Tetrahymena mating cells, when they are forming
new macronuclei during conjugation. Transformants are selected by antibiotic resistance.
2.5

Cytoskeletal Proteins in T. thermophila

A.

Microtubules

Microtubules localize to basal bodies, ciliary axonemes, and other regions of the
cortex. The Tetrahymena thermophila genome contains genes for one alpha-tubulin
(ATU1), one gamma-tubulin (GTU1), and two beta-tubulin genes (BTU1 & BTU2)
(Libisova and Draber 2006). Tetrahymena expresses three alpha-tubulin and two betatubulin isotypes, three of the alpha isotypes and one of the beta isotype is exclusively
found in ciliary microtubules (Suprenant et al., 1985). Gamma-tubulin localizes in
vegetative cells to basal bodies (BBs), macronuclear envelopes, micronuclear envelopes,
and contractile vacuole pores (Shang et al., 2002).
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B.

Actin

Act1 is the least divergent of the four Tetrahymena actin homologs (Williams et al.,
2006). ACT1 consists of 1128 nucleotides and lacks any introns (Cupples and Pearlman,
1986). The actin protein consists of 375 amino acids, 74% identical to yeast actin and is
predicted to have a mass of 42 kDa (Cupples and Pearlman, 1986). Tetrahymena actin
shares ubiquitous features with its homologs that include polymerization into filaments in
the presence of potassium and magnesium ions, and the decoration of heavy meromyosin (Hirono et al., 1989). Cytochalasin B (Spuddich and Lin, 1972), and Latrunculin
A (Coué et al., 1987) are commonly used drugs that inhibit actin polymerization,

conversely, phalloidin promotes actin polymerization (Lengsfeld et al., 1974).
Phalloidin, however, does not bind to Tetrahymena actin (Hirono et al., 1989).
Immunobodies raised against a synthetic actin N-terminus peptide localized to the
division furrow of dividing cells, as well as the oral apparatus, phagosomes, cytoproct,
ciliary meridians and intranuclear microfilament bundles induced by various stresses
(Hirono et al, 1987). Immunogold labeled anti-actin localized to actin epitopes in four
distinct regions of a filamentous complex that surrounds each basal body in the oral
apparatus (Hoey and Gavin, 1992). GFP-tagged actin localized to basal bodies,
phagosomes, and cytokinesis-related contractile ring in dividing cells (Hosein et al.,
2003). Phenotype of the ACT1 knockout include: paralysis in motility, arrested
cytokinesis, deficiencies in phagosome formation and minor aberrations in ciliary
axonemes (Williams et al., 2006). The mRNA levels of ACT1 is very similar to that of
ATU1 (alpha-tubulin) and BTU2 (beta-tubulin).
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2.6

Myosin in Tetrahymena

Myo1 is the founding member of the 13 Tetrahymena thermophila myosins
(Garcés and Gavin, 1998). Myo1 was initially assigned to myosin class XX but more
recently re-assigned to a subclass within class XIV (reviews, Berg et al., 2001; Williams
and Gavin, 2005; Foth, 2006). The tail of this myosin contains a MyTH4/FERM coupled
domain. Myo1 has a mass of 210,889 Daltons and contains 1809 amino acids that include
an 89 amino acid N-terminus extension to the 756 amino acid motor, a MyTH4 (myosintail-homology 4) domain that extends from amino acid 1234 through and including 1376,
and a FERM domain that extends from amino acid 1381 through and including 1799. The
Myo1 motor contains a putative internal calmodulin-binding site, termed IQ (review,
Cheney, 1992; Rhoads and Friedberg, 1997; Gillespie and Cyr, 2002), which begins with
amino acid 758 and ends in amino acid 769.
2.7

What is the Function of Myo1 in Tetrahymena thermophila?

Despite the redundancy of 13 myosins in T. thermophila a somatic knockout (KO)
of MYO1 in Tetrahymena thermophila displays a phenotype (Williams et al., 2000); and
in the last 10 years, this KO has enhanced our knowledge in understanding the innerworkings of cellular trafficking in Tetrahymena (Hosein et al., 2005; Hosein and Gavin,
2007). Some of the morphological abnormalities in Myo1 mutants include: smaller
cytoplasmic to nuclear ratio, defect in macronuclear elongation which probably explains
the longer doubling time at 20ºC, and reduced rate of vacuole formation at 20ºC
(Williams et al., 2000). In the KO phagosome motility was random in contrast to wild
type Tetrahymena in which phagosomes moved in a directed manner toward the posterior
of the cell (Hosein et al., 2005). A peptide polyclonal antibody targeting the motor
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domain of Myo1 localized to phagosomes and the nucleus (Hosein and Gavin, 2007).
Some phagosomes trafficked to the macronucleus in a Myo1 dependent manner (Hosein
and Gavin, 2007). The authors speculate that trafficking of phagosomes to the nucleus
could transport actin and myosin to the nucleus where they function in amitosis (Hosein
and Gavin, 2007).
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Chapter 3

Objectives and Experimental Design

Objective
An objective of this research project is to determine how Myo1 localizes to
microtubule and actin targets within the cell. An additional objective is to determine
whether MyTH4 or FERM region is sufficient for localization to Myo1 targets. We also
wish to determine whether MyTH4 and FERM have overlapping or distinct roles in the
function of Myo1.

Hypothesis
Myo1 is hypothesized to interact with microtubule and actin filament sites
through its MyTH4/FERM coupling. MyTH4 and FERM are hypothesized to bind to MT
and AF, respectively. MT-linked MyTH4 and AF-linked FERM are hypothesized to
synergistically direct Myo1 to its targets.

Experimental Approach & Design
The general experimental approach was to create truncations of Myo1 that contain
various regions of the MyTH4/FERM coupling. The truncated myosins were expressed
in Tetrahymena. Expressed truncations were localized by confocal microscopy and
analyzed for binding partners by low speed cosedimentation assays,
coimmunoprecipation, and coimmunoflorescence.
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Chapter 4
4.1

MyTH4 and FERM Have Overlapping Functions in Myo1
Genomic Analysis of Myo1

MYO1 consists of 6,337 base pairs (bp) accession number TTHERM_00112430,
is located on positions 101,149 through and including 107,485. MYO1 has 8 introns that
are spliced out to create a 5,430 bp mRNA transcript that includes a TGA stop triplet.
Myo1 has a mass of 210,889 Daltons with a theoretical pI of 8.76. Myo1 contains
1,809 amino acids (Fig 1) that include an 89 amino acid N-terminus extension to the 756
amino acid motor, a MyTH4 (myosin-tail-homology-4) domain that extends from amino
acid 1,234 through and including 1,376, and a FERM domain that extends from amino
acid 1,381 through and including 1,799. The Myo1 motor contains a putative internal
calmodulin-binding site, termed IQ (review, Cheney, 1992; Rhoads and Friedberg, 1997;
Gillespie and Cyr, 2002), which begins with amino acid 758 and ends in amino acid 769.
Fig. 1

Fig. 1. Myo1, a class XIV myosin. (A) Diagram of Myo1. The oval (aa 1-89)
represents the N-terminal extension. The location of MyTH4 was determined by prosite
(Hulo and et al., 2007). The location of FERM was determined by alignment of the
Myo1 tail domain with Mus radixin.

18

4.2

Bioinformatic Analysis of MyTH4 and FERM

To search for possible binding motifs that could form the basis for MyTH4
interactions, MyTH4 was aligned with sequences that involve actin binding, tubulin
binding, FERM-FERM interactions and nuclear localization. Lee et al. (2004) identified
a cluster of FERM domain amino acids that were proposed to mediate an electrostatic
interaction between actin and talin. In the present study we sought to determine whether
the same cluster of amino acids exists in MyTH4 and, therefore, represent a putative
binding site for actin. The MyTH4 sequence was aligned with the actin-binding site
(ABS1) in the N-terminal FERM domain of Dictyostelium talinB (Lee et al., 2004) and
with one of the four tandem repeats in the tubulin-binding domain of Rattus MAP-2 (Doll
et al., 1993) (Fig. 2). The talin (ABS) and MAP-2 (TBS) sequences loosely matched two
non-overlapping sequences in MyTH4 (Figs. 2A-2B). Alignment of the MyTH4
sequence with (PPKKKRKVED), the nuclear localization sequence (NLS) in Simian
virus 40 large T antigen, revealed an NLS-like sequence in MyTH4 (Fig. 2C). Myo1
FERM (Gotesman et al., 2010) contains a sequence that loosely matched a conserved
radixin FERM sequence (Kitano et al., 2006) reportedly involved in dimerization of
radixin FERM. The alignment in Fig. 2D revealed a similar sequence in MyTH4.
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Fig. 2

Fig. 2. MyTH4 Clustal W alignments. Portions of the MyTH4 sequence are not
shown. (A) Clustal W alignment of Myo1 MyTH4 and the actin-binding sequence in the
N-terminal FERM domain of Dictyostelium talinB. Putative actin-binding sequence in
Myo1 MyTH4 (aa 1249-1348): Identities = 15/51(29%), Positives = 36/51(70%). (B)
Clustal W alignment of Myo1 MyTH4 and the tubulin-binding sequence in Rattus MAP2. Putative tubulin-binding sequence in Myo1 MyTH4 (aa 1343-1373): Identities =
4/31(13%), Positives = 17/31(55%). (C) Clustal W alignment of Myo1 MyTH4 with the
nuclear localization sequence (PPKKKRKVED) for Simian virus 40 large T antigen.
Putative NLS in Myo1 MyTH4 (aa 1337-1360): Identities = 4/10(40%), Positives =
8/10(80%). (D) Clustal W alignment of Myo1 MyTH4 and the conserved FERM
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putative imerization motif (KxxTIxVxxM) in Mus radixin. X= any amino acid. Putative
dimerization sequence in Myo1 MyTH4 (aa 1319-1328): Identities = 2/5(40%), Positives
= 4/5(80%).
To search for putative binding motifs involving FERM, Myo1 FERM was aligned
with the actin-binding sequence (ABS1) in the N-terminal FERM domain of
Dictyostelium talinB (Lee et al., 2004) and with one of the four tandem repeats in the
tubulin-binding domain of Rattus MAP-2 (Doll et al., 1993). The talin sequence loosely
matched two non-overlapping, putative actin-binding sequences in the N-terminal and Cterminal regions of Myo1 FERM (Fig. 3A). The MAP-2 sequence loosely matched two
non-overlapping, putative tubulin-binding sequences in the N-terminal and C-terminal
regions of Myo1 FERM (Fig. 3B). The bold face type in Fig. 3A-B indicates amino acids
that appear in both actin and tubulin-binding sequences. Alignment of Myo1 FERM with
the sequence KxxTIxVxxM, a conserved motif involved in dimerization of FERM in Mus
radixin (Kitano et al., 2006), revealed a closely matched sequence in the N-terminal
region of the FERM domain and another matched sequence in the FERM C-terminal
region. Here, the KxxTIxVxxM motif is referred to as the FERM dimerization sequence
(FDS) (Fig. 3C). Alignment of Myo1 with the C-ERMAD sequence (TKQRIDEFEAL)
(Finnerty et al., 2004) revealed a similar sequence in residues 340-350 in the Myo1 motor
domain (Fig. 3D). Alignment of Myo1 with the ERM alpha helical domain sequence
(TTPxxxxxxE) (Li et al., 2006) revealed a sequence match in Myo1 residues 1046-1055
C-terminus of the motor domain (not shown). An additional search for binding motifs
involved alignment of Myo1 FERM with the nuclear localization sequence
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(PPKKKRKVED) for Simian virus 40 large T antigen. Alignment revealed NLS-like
sequences in both the N-terminus and C-terminus regions of FERM (Fig. 3E).
Fig. 3.
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Fig. 3. FERM Clustal W alignments. Portions of the FERM sequence are not
shown. (A) Clustal W alignment of Myo1 FERM and the actin-binding sequence in the
N-terminal FERM domain of Dictyostelium talinB. Putative actin-binding sequence in
Myo1 FERM N-terminal region (aa 1420-1526): Identities = 15/51(29%), Positives =
34/51(67%). Putative actin-binding sequence in Myo1 FERM C-terminal region (aa
1692-1802): Identities = 11/51(22%), Positives = 29/51(57%). (B) Clustal W alignment
of Myo1 FERM and the tubulin-binding sequence in Rattus MAP-2. Putative tubulinbinding sequence in Myo1 FERM N-terminal region (aa 1492-1565): Identities =
5/31(16%), Positives = 20/31(65%). Putative tubulin-binding sequence in Myo1 FERM
C-terminal region (aa 1687-1718): Identities = 10/31(32%), Positives = 19/31(61%). (C)
Clustal W alignment of Myo1 FERM and the conserved FERM dimerization motif
(KxxTIxVxxM) in Mus radixin. X= any amino acid. Putative dimerization sequence in
Myo1 FERM N-terminal region (aa 1379-1388): Identities = 3/5(60%), Positives =
4/5(80%). Putative dimerization sequence in Myo1 FERM C-terminal region (aa 16891698): Identities = 2/5(40%), Positives = 4/5(80%). (D) Clustal W alignment of Myo1
motor (aa 340-350) with the conserved C-ERMAD sequence (TKQRIDEFEAL).
Identities = 3/11(27%), Positives = 8/11(73%). (E) Clustal W alignment of Myo1
FERM with the nuclear localization sequence (PPKKKRKVED) for Simian virus 40
large T antigen. Putative NLS in Myo1 FERM N-terminal region (aa 1431-1450):
Identities = 7/10(70%), Positives = 7/10(70%). Putative NLS in Myo1 FERM C-terminal
region (aa 1743-1752): Identities = 2/10(20%), Positives = 8/10(80%).
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4.3

Putative Binding Motifs in MyTH4 and FERM

Overexpression of GFP-MyTH4 and GFP-FERM in Tetrahymena thermophila
was used to investigate the role of putative actin and tubulin binding motifs in the
function of MyTH4 and FERM (Figs 4 and 5). GFP-MyTH4 and a truncated version of
the MyTH4 were separately expressed in Tetrahymena (Fig 4). GFP-MyTH4 contained
the entire GFP-MyTH4 domain (Fig 4B). GFP-MyTH4T contains the entire MyTH4
sequence N-terminal to the putative TBS (Fig 4C).
4.4

MyTH4 Overexpression Constructs

Fig. 4.

Fig 4. Myo1, a class XIV myosin. (A) Diagram of Myo1. The oval (aa 1-89)
represents the N-terminal extension. Diagrams of constructs prepared from truncated
Myo1-tail domains. (B) GFP-MyTH4. (C) Truncated GFP-MyTH4. Actin Binding
Sequence (ABS) and Tubulin Binding Sequence (TBS) are indicated within the ovals in
the diagram.
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4.5

FERM Overexpression Constructs

GFP-FERM and two truncated FERM domains derived from GFP-FERM were
separately expressed in Tetrahymena to test putative binding sequences. GFP-FERM
contained the entire Myo1 FERM domain (Fig. 5B). Truncated Myo1 FERM domains
contained either the N-terminal or the C-terminal region of FERM and one putative
sequence for actin binding, one for tubulin binding, a putative dimerization motif, and a
NLS-like sequence.
Fig. 5.

Fig 5. Myo1, a class XIV myosin. (A) Diagram of Myo1. The oval (aa 1-89)
represents the N-terminal extension. The location of FERM was determined by alignment
of the Myo1 tail domain with Mus radixin. (B) Diagrams of constructs prepared from
truncated Myo1-tail domains. Actin Binding Sequence (ABS) and Tubulin Binding
Sequence (TBS) are indicated within the ovals in the diagram.
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4.6

MyTH4 Overexpression in Transformed Tetrahymena

Expression of GFP-MyTH4 was initiated by addition of cadmium chloride to a
population of transformed cells previously grown for 8-12 hours. Over a 12-hr period
following initiation of over expression, cell density gradually declined, in sharp contrast
to an untreated control population, which remained in exponential phase of growth. To
confirm expression of GFP-MyTH4, total cell lysate was prepared from cells
approximately 8 hours after induction of overexpression. The lysate was analyzed on an
immunoblot probed with GFP antibody, which detected the GFP fusion polypeptide at
the expected relative molecular mass of 47 kDa (Fig. 6A).
Fig. 6.

Fig 6. Gel and immunoblot analysis of GFP-MyTH4 overexpressing cells. (A)
Immunoblot analysis of cells expressing GFP-MyTH4. The blots were probed with
mouse antiGFP. Lane 1: GFP-MyTH4. The fusion protein is 47 kDa. Lane 2: Wild-type
control. (B) Gel and immunoblot analysis of antiactin immunoprecipitation pellets (IP)
from cells overexpressing GFP-MyTH4. Gel loadings were equal for all lanes. Lane 1:
Gel of antiactin IP from GFP-MyTH4. Lane 2: Blot of antiactin IP from GFP-MyTH4.
The blot was probed with anti-GFP. The fusion protein is 47 kDa. Lane 3: Blot of
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antiactin IP from GFP-MyTH4. The blot was probed with mouse antitubulin. Tubulin is
at 55kDa. Lane 4: Gel of antiactin IP from a strain expressing GFP alone. Lane 5. Blot
of antiactin IP from GFP alone. The blot was probed with mouse antiGFP. (C) Gel and
immunoblot analysis of antiactin immunoprecipitation pellet (IP) from cells
overexpressing GFP-MyTH4. Lane 1: Gel of antiactin IP from GFP-MyTH4. Lane 2:
Blot of antiactin IP from GFP-MyTH4. The blot was probed with rabbit antiactin. Actin
is at 42 kDa. The IgG heavy chain is approximately 50 kDa. Lane 3: Blot of antiactin IP
from GFP-MyTH4. The blot was probed with rabbit antiMyo1. Myo1 is at 180 kDa.
The IgG heavy chain is approximately 50 kDa. (D) Gel and immunoblot analysis of
antiGFP pulldown fraction from cells overexpressing GFP-MyTH4. Gel loadings were
equal for all lanes. Lane 1: Gel of affinity purified GFP-MyTH4 fraction. Lane 2: Blot
of antiGFP pulldown fraction. The blot was probed with anti-GFP. The fusion protein is
47 kDa. Lane 3: Blot of antiGFP pulldown fraction. The blot was probed with mouse
antitubulin. Tubulin is at 55 kDa. Lane 4: Blot of antiGFP pulldown fraction. The blot
was probed with rabbit antiactin. Actin is at 42 kDa.
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4.7

Antiactin Antibody Coprecipitates GFP-MyTH4

Clustal alignments indicated a putative tubulin-binding site and a putative actinbinding site within MyTH4. Therefore, to obtain additional evidence that MyTH4
interacts with tubulin and to investigate MyTH4 interaction with actin, non-denatured
lysate from a strain expressing GFP-MyTH4 was processed for immunoprecipitation (IP)
with antiactin, and precipitated proteins were eluted from ProteinA-agarose beads. Actin
antibody coprecipitated GFP-MyTH4, tubulin, actin, and Myo1 (Figs. 6B-6C). The
expression level of Myo1 in overexpressing cells appeared comparable to the expression
level in wild type. In a control experiment, actin antibody precipitated several proteins
from lysate of cells expressing GFP alone, and the control IP gel is quite similar to the
GFP-MyTH4 antiactin IP gel (Fig. 6B). However, GFP was not detected on an
immunoblot of the control IP (Fig. 6B).
4.8

AntiGFP Affinity Pulls Down GFP-MyTH4, Tubulin, and Actin

For affinity purification of GFP-MyTH4, non-denaturing lysate from the GFPMyTH4 strain was incubated with antiGFP-linked agarose. The eluted fraction contained
several polypeptides including GFP-MyTH4, actin, and tubulin (Fig. 6D). Myo1 was not
detected in the eluted fraction.
4.9

GFP-Myo1 Tail Fusions Interact With Actin and Tubulin

To demonstrate that GFP-MyTH4 and GFP-FERM fusions interact with actin and
tubulin in vivo, non-denatured extracts from cells over-expressing GFP-fusions were
used in low speed co-sedimentation assays with either exogenous phalloidin (Alexa-Fluor
568)-stabilized actin filaments or exogenous rhodamine-labeled microtubules. Phalloidin
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does not bind to Tetrahymena actin filaments (Hirono et al., 1989), and therefore the
assay did not detect endogenous F-actin.
4.10

GFP-MyTH4 Associates With Parallel Arrays of Crosslinked Exogenous
Microtubules and Crosslinked Exogenous F-actin

Antiactin IP, antiGFP pulldown fraction, and whole cell extract from the GFPMyTH4 strain were separately used in low speed cosedimentation assays with either
exogenous rhodamine-labeled microtubules or exogenous phalloidin (Alexa-Fluor 568)stabilized F-actin (Fig. 7). Phalloidin does not bind to Tetrahymena F-actin (Hirono et
al., 1989), and therefore the assay did not detect endogenous F-actin. To eliminate
binding of actin to myosin motor domains, actin cosedimentation assays were performed
in the presence of added 10 mM Mg-ATP.
4.11

Cosedimentation Assays of MyTH4 With f-Actin or Microtubules

Examination of the pellet from a cosedimentation assay with microtubules and
antiactin IP revealed significant colocalization of green (GFP-MyTH4) and red
(exogenous microtubules) fluorescence (Figs. 7B-7D). Examination of the pellet from a
cosedimentation assay with labeled F-actin and antiactin IP revealed significant
colocalization of green (GFP-MyTH4) and red (F-actin) fluorescence (Figs. 7F-7H).
GFP alone did not cosediment with either F-actin or microtubules. Next, we asked
whether exogenous F-actin affects microtubule aggregation. A cosedimentation assay
was performed with a mixture of unlabeled F-actin, rhodamine-labeled microtubules, and
antiactin IP. Microtubules appeared to be more extensively crosslinked in the presence of
F-actin (Figs. 7J-7L, Inset). Whole cell extract from the GFP-MyTH4 strain was used in
a cosedimentation assay with either exogenous microtubules (Fig. 7N-7P) or exogenous
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F-actin (Figs. 7R-7T). Significant colocalization of the two signals was observed in the
pellet from each assay. To rule out non-specific aggregation by GFP, a control
experiment used F-actin in the presence of 10 mM Mg-ATP and whole cell extract from a
strain that expressed GFP alone. Examination of the pellet from the control
cosedimentation assay did not detect colocalization of red and green fluorescence as
shown in merged red and green channel images (Fig. 7X). The antiGFP pulldown
fraction was used in cosedimentation assays with either exogenous microtubules or
exogenous F-actin. Figs. 7AA-HH show that the affinity purified GFP-MyTH4
cosedimented with exogenous F-actin and exogenous microtubules, consistent with
cosedimentation assays involving antiactin IP. The images of crosslinked F-actin and
crosslinked microtubules appear highly similar in assays involving either antiactin IP or
the antiGFP pulldown fraction.
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Fig. 7.
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Fig 7. Cosedimentation analysis of GFP-MyTH4 overexpresing cells. Scale bar =
5 µm. (A-D) Cosedimentation of microtubules (red) and antiactin IP from GFP-MyTH4
lysate. (A) Taxol-stabilized microtubules prior to cosedimentation. (B-D) Pellet from
cosedimentation of microtubules and antiactin IP. (B) Microtubule signal. (C) GFP
signal. (D) Image from merged red-green channels. (E-H) Cosedimentation of
phalloidin-labeled, muscle F-actin (red) and antiactin IP from GFP-MyTH4 lysate. (E)
F-actin prior to cosedimentation. (F-H) Pellet from cosedimentation of F-actin and
antiactin IP. (F) F-actin signal. (G) GFP signal. (H) Image from merged red-green
channels. (I-L) Cosedimentation of microtubules (red), unlabeled muscle F-actin, and
antiactin IP from GFP-MyTH4 lysate. (I) Taxol-stabilized microtubules prior to
cosedimentation. (J-L) Pellet from cosedimentation of microtubules, unlabeled F-actin,
and antiactin IP. (J) Microtubule signal. (K) GFP signal. (L) Image from merged redgreen channels. The inset shows a higher magnification of a portion of the microtubule
cross-linked array. The bar in (L) represents 18.5 µm for the inset. (M-P)
Cosedimentation of microtubules (red) and whole cell extract from GFP-MyTH4 strain.
(M) Taxol-stabilized microtubules prior to cosedimentation. (N-P) Pellet from
cosedimentation of Taxol-stabilized microtubules and extract from cells expressing GFPMyTH4. (N) Microtubule signal. (O) GFP signal. (P) Image from merged red-green
channels. (Q-T) Cosedimentation of phalloidin-labeled, muscle F-actin (red) and whole
cell extract from GFP-MyTH4 strain. (Q) F-actin prior to cosedimentation. (R-T) Pellet
from cosedimentation of F-actin (red) and extract from cells expressing GFP-MyTH4.
(R) F-actin signal. (S) GFP signal. (T) Image from merged red-green channels. (U-V)
Cosedimentation of F-actin and extract from cells expressing GFP alone. (U) Phalloidin32

labeled muscle F-actin prior to cosedimentation. (V-X) Pellet from cosedimentation of
F-actin and extract from cells expressing GFP alone. (V) F-actin signal. (W) GFP
signal. (X) Image from merged red-green channels. (AA-DD) Cosedimentation of
phalloidin-labeled, muscle F-actin (red) and antiGFP pulldown fraction. (AA) F-actin
prior to cosedimentation. (BB-DD) Pellet from cosedimentation of F-actin and antiGFP
pulldown fraction. (BB) F-actin signal. (CC) GFP signal. (DD) Image from merged
red-green channels. (EE-HH) Cosedimentation of microtubules (red) and antiGFP
pulldown fraction. (EE) Taxol-stabilized microtubules prior to cosedimentation. (FFHH) Pellet from cosedimentation of microtubules and antiGFP pulldown fraction. (FF)
Microtubule signal. (GG) GFP signal. (HH) Image from merged red-green channels.
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4.12

FERM Overexpression in Tetrahymena thermophila

Expression of GFP-FERM and GFP-FERM truncations was initiated by addition
of 0.1- 0.5 µg/ml cadmium chloride to cultures of transformed cells. GFP fluorescence
was detected within 2-3 hours after addition of cadmium. Transformed cells that overexpressed GFP-fusion proteins exhibited significantly longer doubling times than wildtype cells. For example, at 0.1 µg/ml cadmium chloride the doubling time for the GFPFERM strain was 6.8 + 2.3 hours in contrast to 3.1 + 1.1 hours for wild-type control cells.
Cadmium chloride concentrations greater than 0.1 µg/ml induced longer doubling times.
At 1.0 µg/ml cadmium chloride there was significant cell death, and exponential growth
was not achieved. Lysates from strains that over-expressed GFP-FERM, GFP-FERM-T1,
or GFP-FERM-T2 were analyzed on immunoblots probed with GFP antibody, which
detected GFP-fusion polypeptides at 80 kDa, 64 kDa, and 45 kDa, respectively (Fig. 7A).
GFP-fusion polypeptides were not detected in lysate from a strain over-expressing GFP
alone.
Fig. 8.

Fig 8. Immunoprecipitation (IP) and Immunoblot analysis of GFP-FERM, and
GFP-FERM truncations overexpressing cells. (A) Immunoblots of whole cell lysate from
GFP-fusion strains. Blots were probed with mouse anti-GFP. Lane 1: GFP-FERM. The
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fusion protein is 80 kDa. Lane 2: GFP-FERM-T1. The fusion protein is 64 kDa. Lane 3:
GFP-FERM-T2. The fusion protein is 45 kDa. (B) SDS-PAGE of anti-actin
immunoprecipitation pellets (IP). Gels were stained with Coomassie Blue. Lane 1: Gel
of anti-actin IP from GFP-FERM. Lane 2: Gel of anti-actin IP from GFP-FERM-T1.
Lane 3: Gel of anti-actin IP from GFP-FERM-T2. Lane 4: Gel of anti-actin IP from GFP
alone. Lane 5: Gel of rabbit non-immune serum precipitate from GFP-FERM. (C)
Immunoblots of anti-actin IPs. All blots were probed with anti-GFP.
Lane 1: Blot of anti-actin IP from GFP-FERM. The fusion protein is 80 kDa.
Lane 2: Blot of anti-actin IP from GFP-FERM-T1. The fusion protein is 64 kDa. Lane
3: Blot of anti-actin IP from GFP-FERM-T2. The major band is at 45 kDa. Lane 4: Blot
of anti-actin IP from cells expressing GFP alone. Lane 5: Blot of rabbit non-immune
serum precipitate from GFP-FERM. (D) Immunoblots of anti-actin IPs. All blots were
probed with mouse anti-beta tubulin. Tubulin is 55 kDa in each lane. Lane 1: Blot of
anti-actin IP from GFP-FERM. Lane 2: Blot of anti-actin IP from GFP-FERM-T1. Lane
3: Blot of anti-actin IP from GFP-FERM-T2. Lane 4: Blot of anti-actin IP from GFP
alone.
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4.13

Antiactin Antibody Coprecipitates GFP-FERM

To provide further evidence that FERM interacts with actin and tubulin in vivo,
non-denatured lysate from each strain expressing a GFP-fusion polypeptide was
processed for immunoprecipitation with rabbit anti-actin (Fig. 8B). Actin antibody coprecipitated GFP-fusion polypeptides (Fig. 8C) and tubulin (Fig. 8D). Specifically, the
immunoprecipitation (IP) pellets contained GFP-fusion polypeptides at 80 kDa, 64 kDa,
and 45 kDa from strains expressing respectively, GFP-FERM, GFP-FERM-T1, and GFPFERM-T2 (Fig. 8C). The IP pellets also contained actin and Myo1 (not shown). Two
control experiments were performed to rule out non-specific binding of GFP to actin and
other proteins. In one control experiment, an anti-actin IP pellet was prepared from cells
expressing GFP alone and analyzed on an immunoblot probed with anti-GFP, which did
not detect GFP (Fig. 8C). In another control experiment, GFP was not detected on
immunoblots of precipitation pellets obtained with non-immune serum (Fig. 8C).
4.14

Antiactin Immunoprecipitation Pellets Contain GFP-FERM Fusions
That Interact With f-Actin and Microtubules

IP pellets were used in co-sedimentation assays with either exogenous F-actin or
exogenous microtubules. F-actin and microtubules were randomly distributed prior to
use in the assays (Fig. 9A, E). Examination of the pellets from low speed centrifugation
revealed co-localization of red and green fluorescence in aggregates of exogenous F-actin
(Fig. 9B-D). In parallel assays with exogenous microtubules, examination of cosedimentation pellets revealed co-localization of red and green fluorescence in aggregates
of exogenous microtubules (Fig. 9F-H). To determine whether exogenous actin filaments
affect microtubule aggregation, a co-sedimentation assay was performed with a mixture
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of unlabeled F-actin, rhodamine-labeled microtubules, and IP pellet. Addition of actin
filaments did not appear to affect aggregation of microtubules (Fig. 9G-H). In the
presence of GFP alone, actin filaments and microtubules did not sediment at low speed
centrifugation.
Fig. 9.

Fig. 9. Co-sedimentation assays with anti-actin immunoprecipitation pellets from
GFP-FERM and GFP-FERM truncations. Magnification Bar = 5 µm. (A) Phalloidinlabeled muscle actin filaments prior to co-sedimentation. (B-D) Pellets from cosedimentation of exogenous F-actin (red) and GFP-fusion polypeptides (green). Merged
green and red fluorescence images are shown. (B) GFP-FERM and F-actin. (C) GFPFERM-T1 and F-actin. (D) GFP-FERM-T2 and F-actin. (E) Taxol-stabilized
microtubules prior to co-sedimentation. (F-H) Pellets from co-sedimentation of
exogenous microtubules (red) and GFP-fusion polypeptides (green). Merged green and
red fluorescence images are shown. (F) GFP-FERM and microtubules. (G-H) GFPFERM, microtubules, and unlabeled muscle actin filaments.
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4.15

Cosedimentation Assays of FERM With f-Actin or Microtubules

For cosedimentation essays of GFP-FERM and F-actin and microtubules, F-actin
and microtubules were randomly distributed prior to use in the assay (Fig. 10A, D, G).
Examination of pellets from co-sedimentation of actin filaments and GFP-fusion extracts
revealed co-localization of red and green fluorescence in aggregates of actin filaments in
the presence and absence of added ATP (Fig. 10B-C). In a parallel experiment,
examination of pellets from co-sedimentation of microtubules and GFP fusion extracts
revealed co-localization of red and green fluorescence in aggregates of microtubules (Fig.
10E-F). A control experiment used actin filaments in the presence of 10 mM Mg-ATP
and an extract from cells that expressed GFP alone. Examination of the pellet from the
control co-sedimentation assay did not detect co-localization of red and green
fluorescence as shown in merged red and green images (Fig. 10H-I).
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Fig. 10.

Fig 10. Cosedimentation assays with whole cell extracts of GFP-FERM
overexpressing cells. Magnification Bar = 5 µm. Merged green and red fluorescence
images are shown. (A) Phalloidin-labeled muscle actin filaments prior to cosedimentation. (B-C) Pellets from co-sedimentation of exogenous F-actin (red) and
extract from cells expressing GFP-FERM. (B) F-actin and GFP-FERM in the presence of
10 mM ATP. (C) F-actin and GFP-FERM in the absence of added nucleotide. (D) Taxolstabilized microtubules prior to co-sedimentation. (E-F)

Pellet from co-sedimentation

of exogenous microtubules (red) and extract from cells expressing GFP-FERM. Both
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images are from the same co-sedimentation pellet. (G) Phalloidin-labeled muscle actin
filaments prior to co-sedimentation. (H-I) Pellet from co-sedimentation of exogenous Factin (red) and extract (10 mM ATP added) from cells expressing GFP alone. The red
channel image is shown in (H) and the merged green and red image is shown in (I).
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Chapter 5
5.1

MyTH4 and FERM have distinct functions in Myo1
GFP-MyTH4 Localizes to Myo1 Targets but Predominately in the
Nucleus

Cells overexpressing GFP-MyTH4 were challenged with red fluorescent beads as
a marker for phagosomes and vitally stained with DAPI prior to confocal microscopy.
GFP-MyTH4 localized to the macronucleus, micronucleus, phagosomes, and cytosol
puncta (Fig. 11). To determine whether GFP-MyTH4 colocalizes with endogenous
Myo1, overexpressing cells were challenged with blue fluorescent beads as a marker for
phagosomes and immunostained with antiMyo1. Endogenous Myo1 colocalized with
GFP-MyTH4 to phagosomes (Figs. 11G-11I). To further investigate colocalization of
GFP MyTH4, isolated nuclei from overexpressing cells were immunostained with
antiMyo1 and antiactin. In a previous report on immunolocalization of Myo1, isolated
nuclei were fixed with an ethanol-triton fixative (Hosein and Gavin, 2007). In the present
study, we found that paraformaldehyde fixation revealed significant localization of
antiMyo1 and antiactin within the macronucleus. Both antibodies colocalized with GFPMyTH4 to tubular or filament-like structures within the nucleus and puncta at the nuclear
periphery (Figs. 11M-11K). Overexpressed GFP alone did not localize but accumulated
nonspecifically in the cytosol.
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Fig. 11.

Fig. 11. Confocal images of GFP-MyTH4 localization. (A-F) Localization of
GFP-MyTH4 in living Tetrahymena. Cells were stained with DAPI and imaged
approximately 6 hours after initiation of GFP overexpression. Each cell was separately
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imaged with green, blue, and merged green-blue channels. Macronucleus (n).
Micronucleus (arrowheads). (A-C) Scale bar =3.7 µm. The anterior end of the cell is on
the right side of each image. This cell was challenged with fluorescent beads (yellow
fluorescence). (A) GFP signal. (B) DAPI signal. Numerous nuclear fragments are present
in the cytosol. (C) Image from merged green-blue channels. (D-F) Scale bar =3.7 µm.
This cell was not challenged with fluorescent beads. (D) GFP signal. (E) DAPI signal.
Numerous nuclear fragments are present in the cytosol. (F) Image from merged greenblue channels. (G-I) Immunofluorescence localization of Myo1 in cells overexpressing
GFP-MyTH4. Cells were challenged with blue fluorescent beads. Scale bar = 3.7 µm.
The anterior end of the cell is at the top of each image. (G) Image from merged green
and blue channels. (H) Red channel antiMyo1 signal. (I) Image from merged green-red
channels. (J-L) Scale bar =6 µm. Isolated nuclei from GFP-MyTH4. Arrowheads locate
the micronucleus. (J) GFP signal. (K) DAPI signal. (L) Image from merged green-blue
channels. (M-R) Scale bar =xx µm. Immunofluorescence localization of Myo1 and actin
in isolated nuclei from cells overexpressing GFP-MyTH4. (M) GFP signal. (N) Red
channel antiMyo1 signal. (O) Image from merged green-red channels. (P) GFP signal.
(Q) Red channel antiactin signal. (R) Image from merged green-red channels.
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5.2

GFP-FERM Fusions Localize to Myo1 Targets but Predominately in the
Cytosol

To determine whether FERM or truncations of FERM localize to Myo1 targets,
cells expressing GFP-fusions were observed with confocal microscopy (Fig. 12, Table 1).
Microscopy of living cells that had been challenged with fluorescent beads revealed
localization of GFP-FERM to phagosomes, which often formed confluent aggregates
resulting in large patches of fluorescence (Fig. 12A). GFP-FERM localized to vacuoles
and puncta within nucleoplasm (Fig. 12B-C, 12D, 12F). Localization of GFP-FERM to
microtubule and actin filament sites within the cytoskeleton is demonstrated by the
fluorescent, crescent-shaped oral apparatus at the anterior of the cell (Fig. 12I-J), anterior
to posterior fluorescent rows of basal bodies (Fig. 12I-P), and transverse fluorescent
fibers between rows of basal bodies (Fig. 12N). Phagosomes and puncta associated with
the anterior to posterior alignment of basal bodies (Fig. 12I-P). The puncta were often
DAPI-positive (Fig. 12I-J). Localization of GFP-FERM to cilia was not observed.
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Fig 12.

Fig. 12.
Localization of GFP-FERM in living Tetrahymena. Magnification Bar =3.7 µm.
Fluorescent beads are yellow, n = nucleus. (A) A cell challenged with fluorescent beads.
Cells immobilized in agarose frequently become spherical. (B-C) Images from a x-z
series through a cell that had been challenged with fluorescent beads. Phagosomes
localized to the nucleus. (D) A cell challenged with fluorescent beads and stained with
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DAPI (blue fluorescence) to reveal the nucleus. (E-H) Images from a x-z series. This
cell was not challenged with fluorescent beads. The intense fluorescence is from densely
packed phagosomes. Vacuoles and puncta (F) localized to the nucleus. The oral
apparatus (G-H) is the crescent-shaped fluorescent structure at the anterior of the cell. (IL) Images from a x-z series through a cell challenged with fluorescent beads and stained
with DAPI. The anterior to posterior alignment of basal bodies and the crescent-shaped
oral structure (I-J) at the anterior of the cell are seen in relationship to bead-containing
phagosomes. GFP-fluorescent puncta (I-J) were often DAPI-positive. (M-P) Images
from a x-z series through a cell challenged with fluorescent beads. The cell shows the
association of phagosomes with the anterior to posterior alignment of basal bodies. (N)
GFP-FERM localized to transverse fibers (arrowheads) extending between rows of basal
bodies.

46

5.3

GFP-MyTH4 Affects Division of the Macronucleus

Wild type Tetrahymena contains one macronucleus and one micronucleus. In
cells overexpressing GFP-MyTH4, approximately 4% of a population was
bimacronucleate, and many cells contained abundant macronuclear fragments (Figs. 5A5C). Numerous DAPI-positive puncta accumulate at the cell surface (Fig. 5E). In some
overexpressing cells, GFP-MyTH4 and DAPI colocalized to the central region of the
nucleus, whereas the periphery of the nucleus did not show GFP colocalization (Figs. 5D5F).
Fig. 13.

Fig. 13. Confocal images. Localization of GFP-MyTH4 in living Tetrahymena.
Cells were stained with DAPI and imaged approximately 6 hours after initiation of GFP
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overexpression. Each cell was separately imaged with green, blue, and merged greenblue channels. Macronucleus (n). Micronucleus (arrowheads). (A-C) Scale bar =3.7 µm.
The anterior end of the cell is at the top of each image. (A) GFP signal. (B) DAPI signal.
(C) Image from merged green-blue channels. (D-F) Scale bar =3.7 µm. The anterior end
of the cell is at the top of each image. (D) GFP signal. (E) DAPI signal. (F) Image from
merged green-blue channels.
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5.4

GFP-MyTH4 Affects the Organization of the Intramacronuclear
Microtubule Array and Elongation of the Macronucleus

Clustal alignments indicated a putative tubulin-binding site within MyTH4 (Fig.
2B). Therefore, the strong targeting of GFP-MyTH4 to the macronucleus and the
occurrence of bimacronucleated cells led us to investigate the effect of overexpression on
amitosis of the macronucleus with special focus on intranuclear microtubules. The
organization of the intranuclear microtubules has been extensively investigated with
transmission electron microscopy (Williams and Williams, 1976) and
immunofluorescence microscopy (Fujiu and Numata, 2000). In amitosis, intranuclear
microtubules that are initially random become oriented into an array parallel to the long
axis of the cell (Fujiu and Numata, 2000; Williams and Williams, 1976). Elongation of
the macronucleus is accompanied by elongation of the parallel array of intranuclear
microtubules (Fujiu and Numata, 2000; Williams and Williams, 1976).
In the current study, antitubulin was used to immunostain the microtubule array
and provided the basis for analyzing the effect of overexpression on the progression of
microtubule elongation and nuclear elongation during amitosis (Figs. 14, 15). GFPMyTH4 colocalized with antitubulin to intramacronuclear microtubules (Fig. 15A). A
population of cells was monitored over a 12-hr period following initiation of GFPMyTH4 overexpression. Six hours after initiation of overexpression, 80% of the cells
were in stage I of amitosis in which intranuclear microtubules were assembled but not
organized into a parallel array (Figs. 14, 15A, 15E). The microtubules were often thick
bundles and did not appear to be affected by a 30-min exposure to nocodazole, which
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depolymerized cytoplasmic microtubules (Figs. 15I-15L). Six hours after initiation of
overexpression of GFP-MyTH4, only 5% of the cells had advanced to early stage II of
macronuclear division in which intranuclear microtubules were partially organized into a
parallel array (Figs. 14, 15M, 15Q). The orientation of the microtubule array often did
not appear to be parallel to the long axis of the cell and many of the microtubules within
the array did not appear to extend to the perimeter of the nucleus (Fig. 15M).
Monitoring the population of overexpressing cells for an additional 6-hr period revealed
that the early stage II nuclei and the parallel array of intranuclear microtubules did not
achieve full elongation (Fig. 14). Constriction of partially-elongated stage II nuclei (Fig.
16M) and cytokinesis in the absence of an apparent amitosis (Fig. 15M) led to
uncoupling of macronuclear division and cytokinesis. In contrast, a wild type population
displayed a normal progression of amitosis over a 12-hr interval (Fig. 14). Figs. 15U15W show an early stage in the formation of the intranuclear microtubule array in a wild
type cell. In the wild type image, numerous microtubules were parallel to the long axis of
the cell and extended anteriorly and posteriorly from the array to the perimeter of the
nucleus. In the central region of this nucleus, the microtubules have not fully formed the
parallel organization. The overexpression data for GFP-MyTH4 are consistent with the
MYO1 knockout phenotype in which the normal progression of amitosis fails to occur in
some cells (Williams et al., 2000). Mitosis of the micronucleus appeared to be unaffected
in the overexpression phenotype. Cell density gradually declined over a 12-hour period
of overexpression.
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Fig. 14.

Fig. 14. Nuclear division (amitosis) in Tetrahymena thermophila. Stages of
amitosis (I-V) are diagrammed with emphasis on the orientation and elongation of the
microtubule array and elongation of the macronucleus as observed in wild type cells
immunostained with antitubulin. The distribution (%) of nuclei in various stages of
amitosis is recorded for wild type and MyTH4 overexpression cells. For the
overexpression phenotype, n = 320 cells analyzed. For wild type (WT) n = 210 cells
analyzed. For cells expressing GFP alone (GFP) n = 88 cells analyzed. Stage 0: The
interphase nucleus (dark circle). Stage I: Nucleus with random microtubules. Stage II:
Elongation of the nucleus and the microtubule array. The microtubule array extends to
the perimeter of the macronucleus and is parallel to the long axis of the cell. Stage III:
Intranuclear microtubules elongate. Cytoplasmic microtubules that connect the nuclear
envelope with the cell periphery are not shown. Stage IV: Constriction of the
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macronucleus at its midpoint. Stage V: Completion of macronuclear separation.
Diagram redrawn from Williams et al. (2000).
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Fig. 15.
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Fig. 15. Immunofluorescence localization of tubulin in GFP-MyTH4
overexpressing cells. Cells were fixed 6-hrs after induction of GFP expression. Each cell
was separately imaged with green, red, and blue channels and with merged green-red
channels. The anterior end of the cell is at the top of each image. The white lines allow
identification of the long axis of the cell. However, in each image the cell is magnified
larger than the boundary indicated by the white lines. (A-T) Cells expressing GFPMyTH4. (A-D) Scale bar =1.5 µm. Macronucleus in Stage I of nuclear division. (A)
Antitubulin signal. Intramacronuclear microtubules are evident throughout the nucleus.
Representative microtubules are identified by arrows. Tubulin localization to the cortex
is not evident in this optical section. (B) GFP signal. (C) Image from merged green-red
channels. GFP-MyTH4 and antitubulin show significant colocalization. (D) DAPI
signal. (E-H) Scale bar =5.5 µm. Macronucleus is in stage I. A division furrow
(arrowheads) has formed and cytokinesis will produce an amacronucleate subcell. (E)
Antitubulin signal. Microtubules appear as thick bundles (arrows). (F) GFP signal. (G)
Image from merged green-red channels. (H) DAPI signal. Numerous DAPI-positive
puncta accumulate at the cell surface. (I-L) Scale bar =3.7 µm. Macronucleus in stage 1
in a cell treated with nocodazole. (I). Antitubulin signal Microtubules appear as thick
bundles. (J) GFP signal. (K) Image from merged green-red channels. (L) DAPI signal.
(M-P) Scale bar =1.5 µm. Macronucleus in stage II of nuclear division. (M) Antitubulin
signal. Representative microtubules within the intramacronuclear microtubule array are
identified by arrows. (N) GFP signal. (O) Image from merged green-red channels. GFPMyTH4 and antitubulin show significant colocalization. (P) DAPI signal. Macronuclear
fragments are abundant throughout the cytosol. (Q-T) Scale bar =1.5 µm.
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Macronucleus is in stage II. (Q) Antitubulin signal. Representative microtubules within
the intramacronuclear microtubule array are identified by arrows. (R) GFP signal. (S)
Image from merged green-red channels. (T) DAPI signal. (U-X) Scale bar =1.5 µm.
Optical sections through an early stage II macronucleus in a wild type cell. (U-W)
Antitubulin signal. (X) DAPI signal.
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5.5

Overexpression of a Truncated MyTH4

To determine whether deletion of the putative tubulin binding site within MyTH4
affected the association of MyTH4 with tubulin, a truncated MyTH4 domain that
eliminated the putative tubulin binding motif was fused with a GFP construct and used to
transform Tetrahymena. However, this construct induced death upon induction, and data
was not able to be collected.
5.6

GFP-FERM Affects the Trafficking of Phagosomes and Membrane
Recycling at the Cytoproct

In Tetrahymena, phagosomes are formed in the feeding structure known as the
oral apparatus at the anterior portion of the cell. They are processed into digestive feeding
structures by fusion with lysosomes while transported to the posterior region of the cell.
The membrane material is recycled in the posterior region of the cell by an organelle
known as the cytoproct. The distribution of fluorescence from GFP-FERM is consistent
with localization to the basal body-associated filament complex and transverse
microtubule bands (Fig. 12N). In the overexpression of GFP-FERM truncations,
phagosomes accumulate at the posterior region of the cell (Fig 16) and it seems that this
caused by the overexpression of GFP-FERM truncations. Localization of MyTH4 (Fig.
11), truncated FERM domains containing either the FERM N-terminus region (Fig. 16AD) or the FERM C-terminus region (Fig. 16E-H) was strikingly different from the
localization of GFP-FERM (Table 1, Fig. 12). GFP-MyTH4 localizes to the nucleus.
Truncated FERM domains localized to phagosomes but not to the cytoskeleton or the
nucleus. Confluent aggregates of phagosomes were often located in the posterior region
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of cells over-expressing truncated FERM domains. Cells expressing GFP without FERM
displayed un-localized fluorescence throughout the cytosol.
Fig 16.

Fig 16. Localization of truncated GFP-FERM domains in living
Tetrahymena challenged with fluorescent beads (yellow). Magnification Bar =3.7 µm.
(A-D) Localization of GFP-FERM-T1 containing the N-terminal region of FERM.
Images from a x-z series.

(E-H) Localization of GFP-FERM-T2 containing the C-

terminal region of FERM. Images from a x-z series.
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Chapter 6
6.1

Discussion for MyTH4 and FERM
Overexpression of GFP Fusions

Expression of Tetrahymena genes in heterologous hosts such as bacteria is highly
problematic due to the unusual codon usage in Tetrahymena (Horowitz and Gorovsky,
1985) in which TAA and TAG code for glutamine. Myo1 MyTH4 contains 7 and FERM
contains 49 TAA or TAG stop codon triplets. Therefore, in this study, the Tetrahymena
expression system is the method of choice for investigating interactions between MyTH4
and FERM and cytoskeleton proteins. Homologous-host expression allows investigation
of endogenous binding partners whether direct or indirect.
6.2

MyTH4 Interacts With Intranuclear Tubulin and Actin

Antiactin coprecipitates GFP-MyTH4, tubulin, actin, and Myo1. AntiGFP
affinity pulls down GFP-MyTH4, tubulin, and actin. These two experimental
observations are strong indications that GFP-MyTH4 interacts with tubulin and actin.
However, presence of additional proteins in both the IP and the antiGFP pulldown makes
it difficult to conclude whether the binding of actin and tubulin is direct or indirect. In
the cosedimentation experiments, MyTH4 associates with crosslinked F-actin and
crosslinked microtubules. If there were direct binding of tubulin and actin to MyTH4,
crosslinking of the polymers could be problematic because Clustal W alignments suggest
only a single putative tubulin binding site and one actin binding site within MyTH4.
Therefore, if the observed crosslinking were a function of direct binding to MyTH4,
interaction between two MyTH4 domains would be required. Studies of FERM-FERM
interactions indicate MyTH4-MyTH4 interactions are at least feasible. ERM family
proteins, e.g., ezrin are known to exist as monomers and dimers, and two associated
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FERM/ C-ERMADs (C-terminal ERM association domain) have been proposed to exist
within the dimer (Chambers and Bretscher, 2005; Bretscher et al., 1995). Studies of
radixin FERM dimers identify a sequence that is proposed as the site involved in
dimerization of FERM (Kitano et al. 2006). Interestingly, the radixin sequence loosely
matches a sequence in Myo1 FERM (Gotesman et al., 2010) and in Myo1 MyTH4 (Fig.
2). In the light of these studies of ERM proteins, it is therefore intriguing to speculate
that for Myo1 both FERM and MyTH4 could form dimers. Formation of MyTH4 dimers
or dimerization of MyTH4 with any of the five Tetrahymena myosins that contain
MyTH4 domains could be sufficient for crosslinking either microtubules or F-actin.
Crosslinking of F-actin occurs in the presence and absence of added nucleotide and is
therefore independent of the actin-binding site in the myosin motor domain.
6.3

MyTH4 Localizes to Myo1 Targets and Affects Myo1 Function

Two important observations indicate MyTH4 targets the same sites as Myo1 and
affects Myo1 function. GFP-MyTH4 and Myo1 colocalize to the interior to the nucleus,
and the GFP-MyTH4 overexpression phenotype partially mimics the MYO1 knockout
phenotype. In both overexpressing cells and MYO1-knockout cells, macronuclear
elongation fails to properly occur, cytokinesis and division of the macronucleus are
uncoupled, and consequently, division progeny often contain two macronuclei or no
macronucleus.
6.4

Elongation and Constriction of the Macronucleus

The precise role of intranuclear microtubules in elongation and constriction of the
nucleus is not fully understood. It is unclear whether polymerization of microtubules or
sliding of microtubules is a driving force for nuclear elongation. Alternatively,
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elongation of microtubules could depend upon elongation of the nucleus. Two studies
specifically connect tubulin with effects on nuclear elongation and constriction. In one
study, a mutation in a beta tubulin gene is associated with failure of macronuclear
elongation and constriction resulting in amacronucleated cells at cytokinesis (Smith et al.,
2004). Another study suggests that force production for elongation and constriction does
not depend entirely on microtubule dynamics. Macronuclei in colchicine-treated cells
initiate the elongation process in the absence of intranuclear microtubules, but the nuclei
do not fully elongate and do not constrict into two subnuclei (Williams and Williams,
1976). Application of colchicine to fully elongated macronuclei does not prevent
constriction into subnuclei.
Elongation and constriction of the macronucleus could also involve actin, perhaps
in association with microtubules. Antibodies against actin and Myo1p colocalize to the
the macronucleus. Knockout of MYO1 severely impairs elongation of the nucleus during
nuclear division and is indirect evidence that actin is involved in elongation (Williams et
al., 2000). Interestingly, knockout of an actin gene (ACT1) in Tetrahymena does not
appear to affect cytokinesis or nuclear division (Williams et al., 2006). However,
overexpression of ACT1 leads to failure of macronuclear elongation (Hosein et al., 2003).
6.5

Overexpression of GFP-MyTH4 Affects Organization of the MT Array,
a Possible Driving Force for Elongation of the Macronucleus

During a 12-hr period of overexpression of GFP-MyTH4, more than 90% of the
cells are permanently arrested in stage I of amitosis, and the intranuclear microtubules
fail to become organized into a parallel array. The microtubules appear as thick bundles
suggesting a highly crosslinked structure. Interestingly, nocodazole did not appear to
60

affect the bundle-like appearance of intranuclear microtubules, perhaps due to extensive
crosslinking of the microtubules. Five percent of overexpressing cells organize the
intranuclear microtubules into a parallel array, but the microtubules and nucleus fail to
achieve full elongation. Partially-elongated nuclei apparently constrict into two
subnuclei that remain in one subcell at cytokinesis thereby producing bimacronucleate
and amacronucleate subcells and uncoupling nuclear division and cytokinesis (Fig. 13G13I). Additionally, overexpression appears to lead to an aberrant orientation of the
microtubule array, which is not parallel to the long axis of the cell (Fig. 14E). Failure of
intramacronuclear microtubules to form parallel arrays, failure of the macronucleus to
elongate, and aberrant constriction of the macronucleus indicate MyTH4 interaction with
microtubules affects microtubule organization and elongation of the macronucleus. One
could argue that elongation of the macronucleus requires a parallel array of microtubules
and that polymerization of microtubules within the array could be a driving force for
nuclear elongation.
6.6

GFP-MyTH4 Affects Myo1 Function

Several observations suggest that GFP-MyTH4 specifically contributes to Myo1
function and that it is unlikely the GFP-MyTH4 phenotype is a nonspecific effect of
overexpressed GFP. GFP-MyTH4 and Myo1 colocalize, and the overexpression
phenotype mimics the knockout phenotype with respect to elongation of the
macronucleus and uncoupling of macronuclear division and cytokinesis. GFP-MyTH4
specifically targets intramacronuclear microtubules and is not randomly accumulated in
the nucleus. Targeting of GFP-MyTH4 to intranuclear microtubules could involve a
specific posttranslational modification of these microtubules (Gaertig and Wloga, 2008;
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Hammonda et al., 2008; Wloga et al., 2008). Furthermore, overexpression of other GFPtagged, truncated tail domains does not lead to accumulation of GFP in the nucleus. For
example, overexpressed truncated GFP-FERM domains comparable in molecular mass to
GFP-MyTH4, do not localize to the nucleus (Gotesman et al., 2010). Interestingly, GFPtagged MyTH4 from Myo9 (amino acids 1049 through 1226), another Tetrahymena
myosin, does not localize and is distributed diffusely throughout the cytosol (unpublished
data). We argue that in light of these various observations, overexpresssed MyTH4
contributes to Myo1 function.
6.7

Proposed Model for Interaction Between MyTH4 and Microtubules

A proposed model for interaction between MyTH4 and microtubules is shown in
Fig. 17. The model is based on a proposed dimerization of MyTH4 in a manner suggested
by the reported dimerization of FERM (Kitano et al., 2008) and is consistent with either
polymerization of microtubules or sliding of microtubules as the driving force for
elongation of the macronucleus. MyTH4 is proposed to bind to the plus end of
microtubules and proposed MyTH4 dimers could crosslink microtubules, converting
random microtubules into an array that is oriented parallel to the long axis of the cell. In
overexpressing cells, the orientation of the microtubule array frequently is not parallel to
the long axis of the cell. Overabundance of MyTH4 could lead to excessively
crosslinked microtubules, which would not form parallel arrays. Another prediction of
the model is that overabundance of MyTH4 accumulates at the plus ends of microtubules
and could create a cap that could prevent elongation of microtubules and thereby
eliminate the force of polymerization required for elongation of the nucleus.
Cosedimentation assays are consistent with the proposed model. GFP-MyTH4
62

cosediments with crosslinked microtubules in which MyTH4 appears to be localized at
one end a microtubule (Fig. 7L, Inset). Colocalization of GFP-MyTH4 and antitubulin is
also consistent with the proposed model. The central region of the microtubule array
displays the most prominent colocalization of GFP-MyTH4 and antitubulin.
Microtubules extend from this region of intense colocalization (Figs. 15G, 15K). The
proposed model, at best, could account for only part of the machinery required for
elongation of the nucleus. Studies of microtubule inhibitory drugs indicate that force
production for elongation of the nucleus does not depend entirely on microtubule
dynamics (Williams and Williams, 1976).
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Fig. 17.
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Fig. 17. A proposed model for the role of MyTH4 in the organization of a microtubule
array. Green = MyTH4, Red = crosslinked microtubules, Yellow = Overlap between
MyTH4 and microtubules. Myo1p through its MyTH4 domain is proposed to bind to the
plus end of microtubules and crosslink the microtubules, which form an array oriented
parallel to the long axis of the cell. Elongation of the microtubule array is accompanied
by elongation of the nucleus as shown at the top of Fig. 16. Excess (overexpression) of
MyTH4 is proposed to create a cap at the microtubule plus end, and consequently, the
microtubules do not reach the perimeter of the nucleus and the orientation of the array
often appears aberrant (Image at bottom of Fig. 15).
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6.8

Analysis of GFP-FERM Overexpression in Tetrahymena thermophila

Immunoblot analysis confirms the predicted molecular mass for the GFP-fusion
polypeptides (Fig. 7). Some fusion polypeptides from strain GFP-FERM-T2 are higher
in molecular mass than the predicted value, a probable indication of post-translational
modification. The three transformed strains that overexpress FERM or a truncated
FERM have apparently different physiological states as indicated by the large variation in
generation times and the significant cell death in the strains expressing a truncated
FERM. The three strains could have perturbations in actin and tubulin dynamics.
Variations in gel profiles of IP pellets from the three strains most likely reflect the
apparent physiological state of each strain.
6.9

Myo1 FERM interacts with actin filaments and microtubules.

Immunoprecipitation assays indicate Myo1 FERM interacts with actin and
tubulin. Actin antibody co-immunoprecipitates GFP-fusions and tubulin from lysate of
strains that over-express GFP-fusions (Fig. 7C-D). Actin antibody immunoprecipitates
tubulin but not GFP from lysate of the strain expressing GFP alone (Fig. 7C-D).
Therefore, it appears unlikely that GFP interacts non-specifically with proteins in IP
pellets.
Co-sedimentation assays reveal that fluorescence from either actin filaments or
microtubules co-localizes with GFP fluorescence in whole cell extracts (Fig. 9) and IP
pellets (Fig. 10) from strains expressing GFP-fusions but not in cell extract from the
strain expressing GFP alone (Fig. 7). These two co-sedimentation assays provide strong
evidence that Myo1 FERM interacts with both actin and tubulin and that the interactions
are not attributable to non-specific binding of GFP. Interactions with actin and tubulin
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could be achieved through direct binding with FERM or through indirect binding
involving accessory proteins that are associated with FERM. SDS-PAGE analysis
reveals several polypeptides in the anti-actin immunoprecipitation pellets consistent with
numerous actin-binding and tubulin-binding proteins that are potential sites for indirect
binding of actin and tubulin to FERM (Fig. 7B). The two putative actin-binding and
tubulin-binding sequences in FERM could cross-link and stabilize actin filaments and
microtubules, respectively. Each truncated GFP-FERM domain contains only one actinbinding sequence and one tubulin binding sequence. However, each truncated FERM
contains a sequence motif for possible dimerization of FERM in vivo and in vitro.
Endogenous Myo1 and other FERM-containing myosins could dimerize with overexpressed FERM and contribute to cross-linking activity. Addition of actin filaments to
microtubule co-sedimentation assays does not appear to significantly enhance the
aggregation of microtubules, an indication that FERM does not appear to influence direct
interactions between actin filaments and microtubules.
Existence of ERM-like binding motifs in the FERM domain and other regions of
Myo1 indicate this myosin could have functions that are independent of its actindependent ATPase activity. ERM-family proteins are inactive when intramolecular
binding of FERM to the C-ERMAD masks binding sites within FERM (Pearson et al.,
2000). Kitano et al. (2006) point out that in both ezrin and radixin, the KxxTIxVxxM
motif overlaps with the actin-binding site and suggest that the motif is involved in
regulation of actin binding. One or both of the KxxTIxVxxM sequences in Myo1 FERM
could be masking motifs that regulate accessibility of actin-and tubulin-binding sites.
Interestingly, the KxxTIxVxxM motif in the C-terminal region of Myo1 FERM overlaps
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with both the C-terminal actin-binding sequence and the C-terminal tubulin-binding
sequence. Another potential function of the KxxTIxVxxM motif could be intermolecular
binding of FERM to form a Myo1 dimer in the absence of apparent coiled-coil domains
in the Myo1 tail. Dimerization of Myo1 could facilitate its motor activity on actin
filaments. A putative FERM binding motif (TKQRIDEFEAL) in the Myo1 motor
domain could provide a site for interaction between FERM and the motor and effectively
mask a binding site for a ligand that, in some way, is involved in regulation of motor
activity. Binding of FERM to the motor would require a conformational change such that
the Myo1 tail would be bent against the motor. Interestingly, studies of a class VII
myosin reveal that in an ATP-dependent manner, the tail domain is bent against the
motor domain and that deletion of a sub-domain within FERM eliminates bending (Yang
et al., 2009).
6.10

FERM is Involved in Localization of Myo1

Previous investigations of Myo1 and actin utilized over-expression of GFP-actin
and immunostaining with a peptide antibody that detects the full-length Myo1 (Hosein et
al., 2003, 2005; Hosein and Gavin, 2007). GFP-actin localizes to the cytoskeleton and
phagosomes. The Myo1 peptide antibody localizes to phagosomes, vacuoles, and puncta
within nucleoplasm, and weakly immunostains basal bodies within the cytoskeleton as
evident in the peripheral immunolabeling of the cell in Fig. 2j and 2l of Hosein and Gavin
(2007). In the present study GFP-FERM localizes to the cytoskeleton, phagosomes, and
both cytoplasmic and nuclear puncta (Fig. 12). The punctate localization of Myo1 FERM
to the nucleus is consistent with the apparent punctate nuclear localization of another
class XIV myosin, Pfmyo-D in Plasmodium falciparum (Chaparro-Olaya et al., 2005).
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GFP-labeled puncta in the cytosol were frequently DAPI-positive and therefore could be
extruded chromatin from the macronucleus. Wild type Tetrahymena frequently
eliminates chromatin from the macronucleus (Cleffmann, 1980). Even though the GFPFERM construct eliminates all of the Myo1 sequence N-terminus of FERM, the truncated
tail localizes to the same targets as the full length Myo1. This finding is a strong
indication that FERM is significantly involved in localization of Myo1 to all of its known
targets.
Localization of GFP-FERM to puncta and vacuoles within the nucleus indicates
trafficking of vacuoles to the nucleus as previously reported (Hosein and Gavin, 2007).
This highly unusual trafficking to the nucleus could involve a NLS associated with the
vacuole membrane. NLS-like sequences are revealed in an alignment of Myo1 FERM
with the NLS (PPKKKRKVED) for Simian virus 40 large T antigen, and a recent study
(Rahaman et al., 2008) demonstrates that the SV40 NLS can target proteins to the nucleus
in Tetrahymena. Localization of FERM to the nucleus is consistent with presence of
NLS-like sequences in both the N-terminus and C-terminus regions of FERM. Failure to
observe localization of truncated FERM domains to the nucleus is an indication that
nuclear localization of FERM requires interaction between N-terminus and C-terminus
sequences within FERM. How vacuoles interact with the nuclear envelope is unknown,
but at least one experimental model involving liposomes should be noted. ERM family
proteins can induce reversible holes in liposomal membranes assembled from neutral and
acidic phospholipids (Saitoh et al., 1998; Takeda et al., 2006). Talin-induced holes in
giant liposomes can allow entry of a spherical liposome larger than 1.0 µm (Saitoh et al.,
1998; Takeda et al., 2006). Although it seems unlikely that perforation of cellular
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membranes occurs in vivo, the liposome model at least raises the possibility that ERM
family and ERM-like proteins function in reversible reorganization of membrane
structure that could drastically alter traffic across the membrane.
Microtubules and actin filaments could mediate localization of FERM. GFPFERM localizes to basal bodies but apparently not to cilia, and it is intriguing to suggest
the possibility that FERM interacts with a post-translational modification such as tubulin
glutamylation, which involves two enzymes that could modify different sites on tubulin
in basal bodies and cilia (Gaertig and Wloga, 2008; Hammonda et al., 2008; Wloga et al.,
2008). Truncated FERM domains contain either the N-terminus region or C-terminus
region of FERM and only one tubulin-binding sequence and one actin-binding sequence.
The truncated domains fail to localize to the nucleus and basal bodies (Fig. 13), possibly
a reflection of reduced ability to interact with microtubules and actin filaments. Although
localization of FERM can apparently occur independent of other regions of Myo1, it is
possible that redundancy of function within the tail domain could provide multiple
regions that affect localization of Myo1 independent of its FERM domain. That either
the N-terminus region or the C-terminus region of FERM localizes to phagosomes
indicates redundancy of function within the Myo1 tail domain.
6.11

Phagosome Motility on Cortical Rows of Basal Bodies?

Phagosomes align along the anterior to posterior axis of Tetrahymena and move
toward the posterior of the cell while maintaining the alignment (Hosein et al., 2005). In
MYO1 knockout, phagosomes are much less likely to be aligned, and their movement is
random rather than directed toward the posterior of the cell (Hosein et al., 2005).
Putative interaction of phagosomes with basal bodies and the directed nature of
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phagosome motility could depend on transient attachments between phagosomes and
basal body-associated structures within the cell cortex. Cortical structures that could
provide transient attachment sites for vacuoles include the actin-rich filament complex
surrounding each basal body (Hoey and Gavin, 1992) and transverse microtubule bands
extending between rows of basal bodies (Allen, 1967). The distribution of fluorescence
from GFP-FERM is consistent with localization to the basal body-associated filament
complex and transverse microtubule bands (Fig. 12N).
6.12

MyTH4 and FERM Have Overlapping and Distinct Roles in Myo1
Function

Coimmunoprecipitation, antibody pulldown, and cosedimentation assays indicate
both MyTH4 and FERM interact with tubulin and actin (directly or indirectly), and
therefore the two domains display overlapping functions. Localization of MyTH4 and
FERM is consistent with distinct functions for the two domains in Myo1p. MyTH4,
independent of FERM strongly targets intranuclear microtubules, whereas FERM,
independent of MyTH4, localizes to the cytoskeleton. Overexpressed N-terminus and Cterminus truncated FERM domains do not localize to the cytoskeleton (Gotesman et al.,
2010). Therefore, the entire FERM domain, independent of MyTH4, is a sufficient and
required domain for localization to the cytoskeleton.
The contrast between phenotypes from overexpression of either MyTH4 or FERM
is a further indication of distinct roles for the two domains. Overexpression of GFPMyTH4 adversely affects organization and elongation of intramacronuclear microtubules,
elongation of the macronucleus, and the coupling of nuclear and cytoplasmic division.
Trafficking of phagosomes does not appear to be affected in the GFP-MyTH4 phenotype.
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The GFP-MyTH4 overexpression phenotype is severe and over time becomes lethal, a
likely consequence of overabundance of MyTH4 bound to targets of wild type Myo1. In
contrast to overexpression of GFP-MyTH4, cells overexpressing GFP-FERM do not
appear to have abnormalities in elongation and constriction of macronuclei, but
phagosomes abnormally accumulate at the membrane recycling site in the posterior end
of cells overexpressing a C-terminus truncated FERM domain (Gotesman et al., 2010).
A summary of the distinct localization and roles for MyTH4 and FERM is shown
in table 1.
TABLE 1. Localization of Myo1 MyTH4 and FERM
Domain

Construct

Localization

MyTH4
N-terminus MyTH4
FERM
N-terminus FERM
C-terminus FERM

(GFP-MyTH4)
(GFP-MyTH4T)
(GFP-FERM)
(GFP-FERM-T1)
(GFP-FERM-T2)

intranuclear microtubules, phagosomes
expression is lethal
phagosomes, cytoskeleton, nucleus
phagosomes
phagosomes

Table 1. Localization of Myo1 MyTH4 and FERM
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Chapter 7

Concluding Summary

Five of the thirteen Tetrahymena thermophila myosins consist of a
MyTH4/FERM domain that is common to human class VII, X, XV myosins, nematode
class XII myosin, and the divergent Dictyostelium myosin, MyoG. The role of the
MyTH4/FERM domains in the function of these myosins is poorly understood. This
dissertation separates MyTH4 and FERM into separate domains to determine how each
domain serves to function Myo1. We examined whether these domains have similar,
overlapping or discrete roles in the function of Myo1.
Biochemical evidence shows MyTH4 and FERM, to be similar. Each domain is
pulled down by lowspeed centrifugation by exogenous f-actin or microtubules; implying
that these domains act in a complex that crosslinks f-actin and microtubules, and possibly
to each other. Both domains are found in fractions that were separately coimmunoprecipitated with antiactin. Those fractions were also enriched with tubulin. And
those co-immunoprecipitated fractions that are enriched with GFP-Myo1 tail truncations
retained both f-actin and microtubular crosslinking abilities.
However, confocal Microscopy of GFP-MyTH4, GFP-FERM, and GFP-FERM
truncations revealed that each domain localizes in a distinct pattern of Myo1 targets.
GFP-MyTH4 localizes predominately to the nucleus, and colocalizes to intranuclear
microtubules in conjunction to localizing to phagosomes. Whereas, GFP-FERM localizes
to phagosomes, and sparsely to the nucleus as puncta. And GFP-FERM truncations
localize to phagosomes and the cytoskeleton. Phenotypic analysis of overexpression of
distinct GFP-Myo1 truncations reveals that GFP-MyTH4 disrupts the transition from
stage I to Stage II during amitosis in Tetrahymena, by affecting the crosslinking pattern
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of intranuclear microtubules. Whereas, overexpression of FERM affects phagosome
trafficking and recycling at the cytoproct.
Complete localization of FERM to Myo1 targets is consistent with a parallel study
in which a Class VII Myosin (Myo7A) truncated for the second FERM domain in mice
fails to localize to melanosomes, leading to hair bundle defects (Shwander et al., 2009).
Also, MyoVIIa knockout in Dictyostelium discodium inhibits phagocytosis, possibly by
disrupting phagosome trafficking (Titus, 1999; Tuxworth et al, 2001). Similarly,
phagocytosis is affected in bovine pulmonary alveolar macrophages (PAMs) by
inhibition of Myo10, a MyTH4/FERM myosin and expression of Myo10-headless
truncations (Cox et a., 2002). Therefore, the role of Myo1-FERM in affecting
phagosome recycling, localizing to myo1 targets, and interacting with f-actin is consistent
with current research in other FERM myosins. However Myo1-FERM interacting with
microtubules is a novel finding of this work.
Myo1 in Tetrahymena thermophila may associate with microtubules by the
MyTH4/FERM region or by a novel region demonstrated by the ability of MyoVa (a nonMyTH4/FERM myosin) to “randomly diffuse back and forth” on microtubule tracks (Ali
et al., 2006). During nuclear division of Lecudina tuzetae, the nuclear envelope does not
breakdown, microtubule polymerization may act as the “pushing force” to separate the
dividing nucei in L. tuzetae (Kuriyama et al., 2005). If a similar process takes place in
Tetrahymena, then overexpression of the GFP-MyTH4 can crosslink nuclear
microtubules and thereby arrest nuclear division. The six Plasmodium falciparum class
XIV myosins, PfmyoA-F, are differentially expressed in during malaria development and
PFmyoD localizes to segregating nuclear material during the schizont phase of
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development (Chaparro-Olaya et al, 2005). Accordingly, another class XIV myosin,
Myo1, localizes to the nucleus and affects intranuclear microtubules during macronuclear
elongation and is maximally expressed during conjugation.
It appears that MyTH4 and FERM domains have similar and overlapping roles in
the function of Myo1. MyTH4 and FERM function in the crosslinking of f-actin,
microtubules, and possibly the crosslinking of f-actin to microtubules. However, MyTH4
and FERM are active in different regions of Tetrahymena. MyTH4 functions in the
nucleus during the elongation of intranuclear microtubules at macronuclear division,
whereas FERM functions in the cytosolic regions of the cell, at the cytoskeleton and
phagosome and is involved in trafficking phagsomes from the oral apparatus to the
cytoproct and in recycling of membrane material at the cytoproct. Therefore, MyTH4 and
FERM have overlapping roles in the function of Myo1 in terms of association with actin
and tubulin. However, MyTH4 localizes and functions in the nucleus and FERM
localizes and functions in the cytosol and therefore, MyTH4 and FERM have distinct
responsibilities in Myo1 function. Although many roles for myosin in the nucleus have
been reported, the exact function of Myo1 in the Tetrahymena nucleus is unclear. But our
speculation that Myo1 is involved in orienting intranuclear microtubules during
macronuclear elongation is consistent with findings that the MyTH4 region of Myo10 in
Xenopous oocytes orients spindle pole bodies during mitosis (Sandquist et al., 2009;
Sandquist and Bement, 2010). The results could provide new insight into the function of
MyTH4 and FERM domains in myosins, kinesins, and non-motor proteins.
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Chapter 8

Methods

Materials and Methods:
Creation of Overexpression Constructs
All MYO1 and Myo1 sequences were accessed using accession code U87268.2
from the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/).
The physical characteristics were analyzed using the protparam tool at The ExPASy
(Expert Protein Analysis System) proteomics server of the Swiss Institute of
Bioinformatics (SIB) (http://www.expasy.ch/tools/protparam.html). Conserved domain
database (CDD) (Marchler-Bauer and Bryant 2004; Marchler-Bauer A et al. 2005;
Marchler-Bauer and et al. 2007), and Prosite (Hulo and et al., 2007) was used to model
the updated sequence of Myo1. ClustalW (Kyoto University Bioinformatics Centers)
alignment of the Myo1 sequence with calmodulin-binding sequence (reviews, Cheney,
1992; Rhoads and Friedberg, 1997; Gillespie and Cyr, 2002,) the Dictyostelium talin
actin-binding site (ABS), the Rattus MAP2 tubulin-binding site (TBS), and the Mus
radixin FERM-dimerization sequence (FDS) were used to search for putative IQ, ABS,
TBS, and FDS sites within Myo1, respectively. Modern DNA recombinant methods were
used to PCR amplify Myo1-tail constructs and clone them into pIGF-1 (pIGF-1 figure).
pIGF-1 was generously donated by Douglas Chalker. Restriction and polymerase
enzymes were purchased from Promega (Madison, WI.), and primers (table 2) were
purchased from Oligos Etc. (Wilsonville, OR.). Wild-type strain 428 Tetrahymena
thermophila template DNA for PCR was isolated by the Stratagene DNA Isolation Kit
(La Jolla, CA.). MYO1 coding sequence was accessed from the NCBI database (accession
code: U87268). Amplify3.1 (Bill Engels, 2005, University of Wisconsin) and Oligotech
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(Oligos Etc.) software was used to design primers (Table 2). The MyTH4 coding region

Disruption Construction

GFP-Myo1 Tail constructs

was synthetically engineered and cloned into pIGF-1.
Primer
Description
1.362 kB
GFP-FERM
w/ Xho I site
1.362 kB
GFP-FERM
w/ Apa I site
1.053 kB
GFP-FERMT1 w/ Xho I
site
1.053 kB
GFP-FERMT1 w/ Apa I
site
0.438 kB
GFP-FERMT2 w/ Xho1
site
0.438 kB
GFP-FERMT2 region
w/ApaI site
5.656 kB
MYO1a
(4262 kB
MYO1) w/
Acc65 I site
5656 kB
MYO1a
(4262 kB
MYO1) w/ Sal
I site
1575 kB
MYO1b
w/ Sac II site
1575 kB
MYO1b
w/ Sac I site

Direction

Sequences

Forward

5’  3’
ATACTCGAGAAAAGTGAGTAAATACAAAGAG
GATGCATCC
5’  3’
TTATGGGCCCTCATTGACTTTTTTCTTATTATTG
TTGTTAC
5’  3’
ATACTCGAGAAAAGTGAGTAAATACAAAGAG
GATGCATCC

Reverse
Forward

Reverse

5’  3’
TTTGGGGCCCTCATTCTTTAGAAGAAAGTGTGT
CATTTAGT

Forward

5’  3’
GAACTATACAAAAACCTCGAGTAAGCAAAGTT
AGCCTACATAC

Reverse

5’  3’
GGTTGGTTGTTTGTTGGGCCCTCATTGACTTTT
TTCTTATTATTG

Forward

5’  3’
GTCGACAAGACAGTTG

Reverse

5’  3’
GGTACCACAAACACTTC

Forward

5’  3’
CCGCGGTTTACGTTTA

Reverse

5’  3’
GAGCTCATTGACTTTTTTC

TABLE 2. List of Primers (restriction site sequences are underlined)
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Creation of MyTH4 and FERM Expression Constructs.
Standard recombinant techniques were used to create a GFP (Green Fluorescent
Protein)-tagged Myo1 MyTH4 (aa 1234-1376) construct by fusing 474 nucleotides of
MYO1 tail DNA sequence to the 3’ of the GFP sequence. An in-frame TGA stop triplet
was fused to the 3’ of the 474 bp of Myo1 tail sequence. The 474 bp of MYO1 tail
sequence includes all of the MyTH4 domain (429 bp) and a spacer tail domain sequence
of 33 bp at the 5’ of MyTH4 and 12 bp of tail sequence at the 3’ of MyTH4. Spacer
sequences are transcribed and translated into 11 amino acids at the MyTH4 N-terminus
and 4 amino acids at the MyTH4 C-terminus. The construct was cloned into an
expression vector containing a metallothionein promoter, and the vector was used to
transform Tetrahymena by biolistic bombardment. Similarly, a GFP-tagged Myo1MyTH4 truncation (aa 1223-1343) construct, which eliminated a putative tubulin binding
site, was created by fusing 360 nucleotides of MYO1 tail DNA sequence to the 3’ of the
GFP sequence. An in-frame TGA stop triplet was fused to the 3’ of the 360 bp of MYO1
tail sequence. The 360 bp of MYO1 tail sequence includes a 33 bp spacer at the 5’ of
MyTH4 and 327 bp of the MyTH4 sequence. The truncated Myo1-MyTH4 construct is
transcribed and translated into the first 109 of the 143 amino acids in the Myo1-MyTH4
tail region preceded by an 11 amino acids N-terminus spacer. Similarly, a GFP-tagged
Myo9-MyTH4 truncation (aa 1049-1226) constructed was created by fusing the genomic
region of the MyTH4 region (bp 3145-3674) DNA to the 3’ end of the GFP cassette.
Each construct was separately cloned into an expression vector containing a
methallothionein promoter, and each vector was used to transform Tetrahymena
thermophila. The organization of Myo1 and the predicted GFP-fusion proteins are
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diagrammed in Fig. 2. The expression vector (pIGF) was developed by Dr. Meng-Chao
Yao, Institute of Molecular Biology, Taipei, Taiwan and kindly donated by Dr. Douglas
Chalker.
Dimensions of Myo1 FERM (Fig. 1) are based on an alignment with Mus radixin
FERM (not shown). Standard recombinant techniques were used to create tagged,
truncated MYO1 tail domains by fusing a GFP (Green Fluorescence Protein) sequence to
the 5’ end of three different regions of the MYO1 tail domain (Fig. 1B). One truncation
of the Myo1 tail domain (GFP-FERM) was created by fusing GFP to the last 1362
nucleotides in the MYO1 tail (aa 1357-1809). Therefore, in GFP-FERM, the entire region
N-terminal to the FERM domain was deleted. In another truncation (GFP-FERM-T1),
GFP was fused to the 5’ end of the first 1038 nucleotides in FERM (aa 1357-1686 )
followed by an inserted TGA stop triplet at the 3’ end of the truncated FERM. For the
third truncation (GFP-FERM-T2), GFP was fused to the 5’ end of the last 438
nucleotides in the MYO1 tail (aa 1675-1809). Each fused MYO1 tail sequence was
separately cloned into an expression vector containing a metallothionein promoter, and
the vector was used to transform Tetrahymena by biolistic bombardment. The pIGF
vector was developed by Dr. Meng-Chao Yao, Institute of Molecular Biology, Taipei,
Taiwan and kindly donated by Dr. Douglas Chalker.
Creation of Replacement Construct:
Modern DNA recombinant techniques were used to create the replacement
construct by independently PCR amplifying two different fragments of MYO1 and
cloning them into sites that flank a disruption cassette. MYO1A is a 5667 bp region of
MYO1 that includes the first 4262 bp coding sequence and 1399 bp leader sequence of
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the MYO1 coding sequence was PCR amplified using forward 5’GGTACCACAAACACTTC-3’ and reverse 5’-GTCGACAAGACAGTTG-3’ primers
(Oligos etc., Wilsonville, OR), and cloned into PCR 2.1 (Invitrogen, Carlsbad, Ca).
Similarly, MYO1B is a 1584 bp sequence of MYO1, 3’ of MYO1A, that was PCR
amplified using forward 5’-CCGCGGTTTACGTTTA 3’ and reverse 5’GAGCTCATTGACTTTTTTC-3’ primers (Oligos etc), and cloned into PCR 2.1
(Invitrogen). MYO1A was cut with RE’s ACC65I and SalI and MYO1B was cut with
RE’s NotI and BamHI and cloned flanking the disruption cassette in the pMrpl29B vector
(kindly donated by Dr. Douglas Chalker). The disruption cassette is composed of a
cycloheximide resistance gene that is under a metallothionein promoter and a
transcriptional terminating sequence that directly flanks the 3’ sequence of MYO1A. The
replacement construct was designed to replace endogenous MYO1 in Tetrahymena by
homologous recombination and transcribe a gene that is translated to express a truncated
Myo1 (amino acids 1-1214) followed by a 6 amino acid spacer and a translational TGA
stop triplet, and therefore will be missing all of the MyTH4/FERM domain.
Strains
Two Tetrahymena strains will be used in this study: wild type CU427 and CU428.
Cells will be grown in Neff’s (Orias et al., 2000) medium at 30o C.
Antibodies
Anti-GFP and appropriate secondary antibodies will be purchased commercially.
Anti-actin and anti-Myo1 are currently available in our lab from previous studies (Hosein
et al., 2003; Hosein and Gavin, 2007).
Mating
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Logarithmically growing cells in Neff’s medium (Orias et al., 2000) will be
concentrated by centrifugation, resuspended in 10 mM Tris-Cl (pH 7.4) to yield an
optical density of 0.2 as measured at 540 nm, and they will be starved overnight at 30
degrees C. Mating will be initiated by mixing equal numbers of cells (approximately 5-ml
total volume) in plastic 45-ml Petri dishes. Conjugal pairs will be formed from CU427
and CU428.
Biolistic Bombardment of Conjugating Tetrahymena
Biolistic bombardment was achieved with a Helios Gene Gun (Bio-Rad,
Richmond, CA). The “bullets” were prepared with 1.0 µm gold particles according to the
protocol described by Woods & Zito (2008). For gun shoots, a concentrated volume of
Tetrahymena conjugal pairs (8-10 hours after mixing the mating types) were placed on
2.4 cm GF/A sterile Whatman filter paper in 100 x15 mm plastic Petri dishes. Cells were
fired upon three consecutive times at pressures of 120 psi, 150 psi, and 180 psi. Seven ml
of modified Neff’s medium containing 1x antibiotic/antimycotic mix (Invitrogen,
Carlsbad, CA) was added to the Petri dishes containing the bombarded cells, was
incubated overnight at 30o C. Bombarded cells were subsequently diluted with modified
Neff’s containing 100 µg/ ml paromomycin and 1x antibiotic/antimycotic mix. Two
hundred fifty µl aliquots will be placed in Costar polypropylene cluster U-bottomed 96
well plates (Corning, Lowell, MA) and were incubated at 30o C. Transformants were
evident within 3-5 days.
Biolistic Bombardment of Conjugating Tetrahymena
Transformation of Tetrahymena with previously described constructs was
achieved by biolistic bombardment (Cassidy-Hanley,D. 1997; Bruns,P J. 2000 ) of
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conjugating Tetrahymena with the Bio-Rad (Hercules, CA) hand-held Helios Gene Gun
by the following method. Wild type 427 and 428 Tetrahymena cells were grown at 30°C
overnight, in bottles that contained 30 ml of modified Neff’s media (Orias et al., 2000).
Logarithmically growing cells were gently centrifuged washed three times, and
resuspended in 30ml of 10 mM Tris-Cl (pH 7.40) to yield an optical density of 0.2 as
measured at 540 nm, and starved overnight. The following day, approximately equal
number of cells were mixed and allowed to mate. Conjugal pairs (8-10 hours after
mixing) were concentrated by gentle centrifugation, placed on sterile 2.4 cm GF/A
Whatman filter paper in 100 x 15 mm plastic Petri dishes, and were fired upon three
consecutive times with fresh “bullets” at pressures of 120 psi, 150 psi, and 180 psi.
Preparation of “Bullets” and Use of Gene Gun.
The “bullets” consist of 1.0 micron DNA coated gold particles that were prepared
by the following procedure adapted from the Woods and Zito (2008) protocol and the
Bio-Rad handbook protocol.
1.

Preparation of DNA

Fresh PolyVinylPyrolidone (PVP) ethanol suspension solution was prepared by
adding 175 µL of 20mg/ml PVP solution in a sterile screw cap container, and the solution
was diluted with fresh ethanol to make a final volume of 3.5ml (i.e. final concentration is
0.01mg/ml PVP). 50 µL of 200 proof ethanol was added to 50 µL of 0.10 spermidine in a
microfuge tube containing 50 mg of 1.0 micron Gold (Au) particles and the mixture was
sonicated and vortexed for 2-3 secs. 100 µg (100 µL) DNA, which was prepared by the
Qiagen (Valencia, CA) HiSpeed Maxi Plasmid Prep Kit, was added to the gold &
spermidine solution, and the mixture was gently sonicated. Drop-wise, 100µl of Calcium
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Chloride (2.5M) was added to the mixture and sonicated for 2-3 minutes. The mixture
was allowed to precipitate at room temperature for 10 min, and then briefly sonicated.
The mixture was pulse-centrifuged for 15seconds, and the supernatant was removed and
discarded. The mixture was resuspended in the remaining supernatant, and washed 3times with 1ml fresh EtOH. After the final wash, repeated 200ul of PVP solution was
used to transfer solution into freshly made PVP solution.
2.

Coating the Plastic (From Bio-Rad protocol):

A ~ 30 inch tube was cut and dried in the tube prep station with Nitrogen at 0.350.4 Liters Per Minute(s) (LPM) for at least 15 minutes. The DNA coated gold mixture
was inverted several times. Most of the mix was drawn and quickly transferred to the
dried tube. The micro-carriers were allowed to settle for 3-5minutes. The solution was
removed at a rate of 0.5-1.0”/ sec (the tube is emptied in within 30-45 secs). The tube was
rotated 180 degrees and the gold was allowed to coat the inside of the tubing for 3-4 secs.
The tubing prep station was turned on (I) to start rotating and the Gold to smeared the
tubing for 20-30 second. The nitrogen valve was later opened to allow Nitrogen out at
0.35-.4LPM for 3-5 minutes. Finally, the rotator was turned off, and the nitrogen valve
was closed.
3.

Cutting the Tubing:

A vial with desiccant pellet inside was placed in the base of the tubing cutter (hole
under the cutter). The tubing was inserted until it made contact with rear. The cutter was
pressed down to cute DNA-coated, gold-smeared tube. Unused bullets were stored at 4°C
in a tightly capped vial labeled, and wrapped in parafilm.
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4.

Using the Gun:

An empty cartridge holder was inserted into the Helios Gene Gun, and the gun
was pressurized to fire at 200 ATM. Loaded bullets were loaded into the cartridge holder
and were fired at unsuspecting Tetrahymena. Bombarded cells were incubated overnight
at 30C and the diluted with modified Neff’s containing 120 µg/ml paromomycin and 1x
antibiotic/antimycotic mix. Two hundred fifty µL aliquots were placed in Corning
(Lowell, MA) 96 well plates and incubated at 30°C. Transformants were evident within
3-5 days.
Verification of Replacement Construct:
Genomic DNA was extracted from wild type 428 and MYO1 truncated
replacement strains of Tetrahymena thermophila using the Stratagene DNA Isolation Kit
(La Jolla, CA.) and were separately used as template for PCR reactions. Two primers
(Eurofins, Huntsville, Al), forward 5’-AGCTATCTGAATTAGGAGAGTAGAAGC-3’
and reverse 5’-CTACTGGTTGTTGGCAGTATGCTG-3’ were used to verify the
replacement of endogenous MYO1. The PCR product for wild type strains expressing
endogenous MYO1 was expected to be 1181 nucleotide bases. The PCR product for the
replacement construct was expected to be 2489 nucleotide bases. The running condition
for the PCR reaction was (94°C, 30 seconds; 62°C, 30 seconds; 72°C, 2:30 minutes; 30
cycles).
Expression of GFP-MyTH4
Transformed cells were grown for 8-12 hours at 30oC prior to induction of GFPMyTH4 expression by addition of 1.0 µg/ml CdCl2. Cells were analyzed 6-12 hours after
induction of GFP-MyTH4 expression.
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Growth Curves
Spectrophotometer analysis at 540 nm was used to measure the growth rate of
wild type and transformed Tetrahymena. Cells were grown in Neff’s media supplemented
with 0.1-0.5 µg/ml cadmium chloride at 30°C in 500 ml of culture medium contained in
2.8 liter Fernbach flasks.
Lysates
GFP-MyTH4 transformants were grown for two nights in 30 ml bottles of Neff’s
media at 30°C, and were treated to three hours of 1.0 µg/ml of CdCl2 the next morning.
However, GFP-FERM transformants cells were grown overnight in 30 ml bottles of
Neff’s media at 30°C. transformant cells were subsequently grown overnight in 0.5 µg/ml
of CdCl2 and incubated another night at 30°C. The cells were lysed with SDS according
to the Hosein et al., 2003 protocol. To minimize protein degradation, Sigma-Aldrich
protease inhibitors (St. Louis, MO) were added to the lysis buffer. Cells were
concentrated and lysed by mixing with a solution consisting of 50 mM Tris-HCl (pH 8.0),
150 mM NaCl, 20 mM EDTA, 1% Na-deoxycholate, 1% Trition X-100 (Williams,
2000), and protease inhibitors (Turkewitz et al., 2000) for co-immunopreciptitation and
low-speed sedimentation assays.
Immunoprecipitations
Lysates were treated with 1ml rabbit anti-actin serum (clone 7167) and incubated
overnight at 4°C. One-milliliter of Protein A-agarose beads (Bio-Rad) was prepared by
washing with Tris-Buffered Saline at pH 8.0 (TBS) until the OD280 was zero and
resuspended in TBS for a total volume of ~1ml. Lysate and antiserum mixture was
incubated with Protein A-agaorse beads for 2 hours in ice water with shaking. The
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immunoprecipitate/Protein A-agarose beads mixture was washed again with TBS, until
the OD280 was zero. Immuno-complexes were eluted with glycine at pH 3.0 from the
beads and the eluate was immediately treated with 1.0M Tris-HCl (pH 8.0) to bring up
the pH to 8.0. The same procedure as described for immune serum was completed with
rabbit non-immune serum treatment with lysate for control experiments.
Affinity Purification with antiGFP-Agarose
Affinity resin was prepared by applying 400 µL of 100 µg/ml GFP polyclonal
antibody (Invitrogen) to an NHS-Activated agarose spin column (33 mg capacity)
(Pierce) and incubating at 4°C overnight. Unbound GFP-antibody was removed by
centrifugation and the column was washed twice with phosphate buffered saline (PBS):
13.7 mM NaCl, 0.27 mM KCl, 10 mM Na2HPO4, 0.2 mM KH2PO4, pH 7.4. Agarose
reactivity was quenched with 1.0 M ethanolamine (pH 7.4), and the quenched spin
column was washed with PBS until OD at 280 was zero. Non-denatured, twice clarified,
whole cell lysate from cells overexpressing GFP-MyTH4 was prepared as described for
immunopreciptation and added to the spin column along with 10 mM Mg-ATP. The
column was incubated overnight at 4°C overnight and subsequently washed with PBS
until OD at 280 was zero. The column was eluted with 400 µL of 0.5 ml glycine (pH
3.0) and neutralized with 25 µL of 1.0 mM Tris (pH 8.0).
Electrophoresis
Lysates were separated on NuPage 4-12% Bis-Tris gels and stained with Novex
colloidal blue from Invitrogen (Carlsbad, California) for gel analysis. Gels were
electrophoretically transferred to PVDF membranes (Bio Rad) using standard methanolbased transfer protocols.
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SDS-PAGE.
Transformed cells were grown overnight in Neff’s medium at 30o C.
Subsequently, CdCl2 at a final concentration of 0.5 µg/ml was added to the culture, which
was again incubated overnight at 30o C. Protocols for SDS-solubilized total cell lysate
were previously described (Hosein et al., 2003). Polypeptides were separated on NuPage
(Invitrogen) 4-12% Bis-Tris gels and stained with Coomassie Blue. Gel loadings were
equal for all lysates.
Immunoblotting
Proteins were electrophoretically transferred to a PVDF membrane (Bio Rad)
using standard methanol-based transfer protocols. Membranes were probed with
appropriate antibodies in accordance with standard methods for immunoblotting.
Immunoblots were developed with ECL Western Blotting Substrate (Pierce) and Biomax
XAR film (Kodak).
Actin Filaments
Muscle F-actin (Cytoskeleton, Inc) was stabilized by treatment with 1.0 µM
Alexa-Fluor 568-phalloidin (Invitrogen) in binding buffer (5.0mM Tris-HCl (pH 8.0), 0.2
mM CaCl2, 2.0 mM MgCl2, 5.0% glycerol).
Preparation of Microtubules
Tubulin and all other reagents for MT polymerization were purchased from
Cytoskseleton, Inc (Denver, CO). Microtubules were polymerized from rhodamine
labeled tubulin mixed with unlabeled tubulin (1:1) according to the manufacturer’s
protocol which is as follows: All reagents including labeled and unlabelled tubulin was
thawed out. Sixty microliter of G-PEM solution was prepared by thorough mixing of 59.4
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µl general tubulin buffer, and 0.6 µl 100mM of GTP. Four microliters of G-PEM solution
and 1 µl of microtubule cushion buffer were added to rhodamine tubulin. Ten aliquots of
unlabelled tubulin were prepared by adding 45 µl of G-PEM solution and 4.5 µl of
Microtubule cushion buffer to unlabelled tubulin. Five micro liters of unlabeled tubulin
solution was added to 5ul rhodamine-labeled tubulin to make a 1:1 ratio. The mixture
was incubated at 35 °C for 25 minutes. Five-hundred micro-liters of General tubulin
buffer was incubated at 35 °C for 15 minutes, followed by the addition 5 µl of taxol to
tubulin buffer and the solution was stored at room-temperature. One hundred microliters
of taxol-tubulin buffer was added to the tubulin after the 25-minute incubation period
ended. The polymerized tubulin was observed by adding 1 µl of tubulin mixture in 20 µl
of tubulin buffer-1x antifade mixture under confocal microscope.
Preparation of Whole Cell Extracts for Cosedimentation Assays
To prepare whole cell extracts, cells were washed free of culture medium and
resuspended in extraction lysis buffer: 10 mM Tris pH 7.4, 20 mM KCl, 0.1 mM EGTA,
5 mM MgCl2, 2 mM DTT, and 200 µl protease inhibitor/ml lysis buffer. The
concentrated cell suspension was frozen at -20 °C for 10 minutes and subsequently
thawed at room temperature, then put through a vigorous vortex and drawn up into a
Pasteur pipette several times to lyse the cells. The lysate was clarified by centrifugation
at 16,000 x g for 15 minutes. The supernatant was centrifuged a second time at 16,000 x
g for 15 minutes. Supernatant from the second centrifugation was used in
cosedimentation assays.
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Cosedimentation Assays With GFP-MyTH4 IP
Phalloidin-stabilized F-actin (15 µM) in binding buffer containing 10 mM ATP
was incubated with 160 µl of antiactin immunoprecipitation (IP) pellet for 15 minutes at
4°C followed by centrifugation at 16,000 x g for 15 minutes. The pellet was resuspended
in 100 µl of actin-binding buffer and subsequently prepared for confocal microscopy.
For microtubule cosedimentation assays 160 µl of antiactin GFP-MyTH4 IP were
incubated with 3.5 µM taxol-stabilized microtubules in polymerization buffer for 15
minutes at 30°C followed by centrifugation at 16,000 x g for 15 minutes. The pellet was
resuspended in 100 µl of binding buffer and used for confocal microscopy. For
cosedimentation assays involving both F-actin and microtubules, 160 µl of antiactin
GFP-MyTH4 IP were incubated with 3.5 µM taxol-stabilized microtubules in
polymerization buffer for 15 minutes, and then 15 µM unlabeled F-actin in actin-binding
buffer containing 10 mM ATP were added for another 15 minutes incubation.
Cosedimentation Assays With Whole Cell Extracts
For actin filament cosedimentation assays, stabilized F-actin (15 µM) was
incubated with 160 µl of the cell lysate (with added 10 mM Mg-ATP) for 15 minutes at
40 C followed by centrifugation at 16,000 x g for 15 minutes. The pellet was resuspended
in 100 µl of actin-binding buffer and subsequently prepared for confocal microscopy.
For microtubule cosedimentation assays, 160 µl of whole cell lysate were incubated with
3.5 µM taxol-stabilized microtubules in polymerization buffer for 15 minutes at 30°C
followed by centrifugation at 16,000 x g for 15 minutes. The pellet was resuspended in
100 µl of binding buffer and used for confocal microscopy. F-actin and microtubules
were viewed from wet mounts sealed with nail polish.
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Cosedimentation Assays with AntiGFP Pulldown Fraction
For actin filament cosedimentation assays, stabilized F-actin (15 µM) was
incubated with 160 µl of antiGFP pulldown (with added 10 mM Mg-ATP) for 15 minutes
at 4oC followed by centrifugation at 16,000 x g for 15 minutes. The pellet was
resuspended in 100 µl of binding buffer and used for confocal microscopy For
microtubule cosedimentation assays, 160 µl of antiGFP pulldown fraction were incubated
with 3.5 µM taxol-stabilized microtubules in polymerization buffer for 15 minutes at 300
C followed by centrifugation at 16,000 x g for 15 minutes. The pellet was resuspended in
100 µl of binding buffer and used for confocal microscopy.
Confocal Microscopy of Living Cells
Living cells were embedded in a thin layer of 1.7 % low melting agarose on slide.
Actin filaments and microtubules were viewed from wet mounts sealed with nail enamel.
For observation of nuclei, DAPI (4’, 6-diamidino-2-phenylindole, dihydrochloride) was
used at a concentration of 10 µg/ml. Confocal microscopy was performed with a C-1
confocal system (Nikon, Inc., Melville, NY). A 60x 1.4 N.A. Nikon Apochromat oil
immersion lens was used to capture images.
Isolation of Nuclei
To prepare a cell fraction enriched for nuclei, cells were washed free of culture
medium and resuspended in extraction lysis buffer: 10 mM Tris pH 7.4, 20 mM KCl, 0.1
mM EGTA, 5 mM MgCl2, 2 mM DTT, and 200 µl protease inhibitor (Sigma)/ ml lysis
buffer. The concentrated cell suspension was frozen at -20°C degrees for 10 minutes and
subsequently thawed at room temperature, then gently drawn up into a Pasteur pipette
several times to lyse the cells without rupturing nuclear membranes. The extract was
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centrifuged at 800 x g for 10 minutes. The supernatant was discarded; the pellet was
resuspended in extraction buffer and centrifuged a second time at 800 x g for 10 minutes.
The supernatant from the second centrifugation was discarded; the pellet, which
contained intact nuclei, was resuspended in 100 µl extraction buffer and used for
microscopy analysis.
Nocodazole
Cells overexpressing GFP-MyTH4 were given a 30 minute treatment with 30 mM
nocodazole prior to fixation for immunofluorescence microscopy. Control cells received
a 30-minute treatment with DMSO prior to processing for immunofluorescence
microscopy.
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Chapter 9.

Closing Remarks

Replacement Construct for MYO1
A Replacement construct for MYO1 was used to transform Tetrahymena with a
truncated version of Myo1 that lacked MyTH4/FERM region of Myo1. PCR confirmed
replacement of endogenous Myo1 gene, and immunoblot analysis showed stable
expression of truncated Myo1 (not shown). However, complete phenotypic assortment
for this gene was not achieved, as observed in PCR analysis and western blots, implying
that Myo1 truncated for MyTH4/FERM is lethal to Tetrahymena.

92

Chapter 10

Bibliography

Adams, R. J., and Pollard T.D. (1986). Propulsion of organelles isolated from
Acanthamoeba along actin filaments by myosin-I. Nature, 322(6081), 754-756.
Adams, R. J., and Pollard T.D. (1989). Binding of myosin I to membrane lipids. Nature,
340(6234), 565-568.
Allen RD. 1967. Fine structure, reconstitution, and possible functions of components of
the cortex of Tetrahymena pyrifoirmis. J Protozool 14, 553-565.
Allen, R., & Wolf, R. (1979). Membrane recycling at the cytoproct of Tetrahymena.
Journal of Cell Science, 35(1), 217-227.
Awan, A., Hamasaki, T., and Satir, P. (2004). Cloning and characterization of Kin5, a
novel Tetrahymena ciliary kinesin II. Cell Motility and the Cytoskeleton, 58, 1-9.
Banga, I. (1942). The phosphatase activity of myosin. Stud. Inst. Med. Chem. Univ.
Szeged. (I), 27–36.
Banga, I., and A. Szent-Györgyi. (1942). Preparation and properties of myosin A and B.
Stud. Inst. Med. Chem. Univ. Szeged. (I), 5-15.
Barsoum, I.B., King-Smith, C., Myosin II and Rho kinase activity are required for
melamosome aggregation in fish retinal pigment epithelial cells. (2007). Cell
Motility and the Cytoskeleton, 64, 868-879
Basciano, P. A. & King-Smith, C. (2002) Pigment Cell Res. 15 , 184–191.
Belyantseva, I.A., Boger, E.T., Naz, S., Frolenkov G.I., Sellers J.R., Ahmed Z.M.,
Griffith, A.J., and Friedman T.B. (2003). Myosin XVa localizes to the tips of
inner ear sensory cell stereocilia and is essential for staircase formation of the hair
bundle. Proc Natl Acad Sci USA., 100(24), 13958-13963.
Belyantseva, I.A., Boger, E.T., and Friedman T.B. (2005). Myosin-XVa is required for
tip localization of whirlin and differential elongation of hair-cell stereocilia.
Nature Cell Biology, 7, 148-156.
Berg JS, Derfler BH, Pennis CM, Corey DP, Cheney RE. 2000. Myosin-X, a novel
myosin with pleckstrin homology domains, associates with regions of dynamic
actin. J Cell Sci 113, 3439-3451.

93

Berg, J., Powell, B., & Cheney, R. (2001). A millennial myosin census. Molecular
Biology of the Cell, 12(4), 780-794.
Blackburn, E. H. (1978). A tandemly repeated sequence at the termini of the
extrachromosomal ribosomal RNA genes in tetrahymena. Journal of Molecular
Biology, 120(1), 33-53.
Bleyman, L. K. (1992). Mapping the mating type locus of Tetrahymena thermophila:
Meiotic linkage of mat to the ribosomal RNA gene. Devel Genetics, 13(1), 34-40.
Bohil, A. B., Robertson, B. W., & Cheney, R. E. (2006). Myosin-X is a molecular motor
that functions in filopodia formation. PNAS USA, 103(33), 12411-12416.
Breshears LM, Wessels D, Soll DR, Titus MA. 2010. An unconventional myosin
required for cell polarization and chemotaxis. PNAS USA 107, 6918-6923.
Bretscher A, Edwards K, Fehon RG. 2002 ERM proteins and merlin: integrators at the
cell cortex. Nat Rev Mol Cell Biol., 3, 586-599.
Bretscher, A., Reczek, D., & Berryman, M. (1997). Ezrin: A protein requiring
conformational activation to link microfilaments to the plasma membrane in the
assembly of cell surface structures. Journal of Cell Science, 110(24), 3011-3018.
Bruns, P.J. (1986). Genetic organization of Tetrahymena. In: Gall, L. G. (ed.),
TheMolecular Biology of Ciliated Protozoa. Academic Press, Orlando. p. 27-44.
Bruns, P. J., and Cassidy-Hanley, D. (2000). Biolistic transformation of macro- and
micronuclei. In: Asai, D.J., and Forney, J.D. (ed), Tetrahymena thermophila.
Methods in Cell Biology, V(62). Academic Press, San Diego. p. 501-512.
Brzeska, H., Lynch, T., & Korn, E. (1988). Localization of the actin-binding sites of
acanthamoeba myosin IB and effect of limited proteolysis on its actin-activated
Mg2+-ATPase activity. Journal of Biological Chemistry, 263(1), 427-435.
Cassidy-Hanley, D., Bowen, J., Lee, J. H., Cole, E., VerPlank, L. A., Gaertig, J.,
Gorovsky, M.A. and Bruns, P.J. (1997). Germline and somatic transformation of
mating tetrahymena thermophila by particle bombardment. Genetics, 146,135-47.
Cao, T.T., Chang, W., Masters, S.E., and Mooseker M.S., (2004). Myosin-Va Binds to
and Mechanochemically Couples Microtubules to Actin Filaments. MBC., 15(1),
151-161.

94

Chambers DN, Bretscher A. 2005. Ezrin mutants affecting dimerization and activation.
Biochemistry 44, 3926-3932.
Cech, T.R. 1986 . A model for the RNA-catalyzed replication of RNA. Proc Natl Acad
Sci USA., 83(12), 4360-4363.
Chasey, D., (1969). Observations on the Central Pair of Microtubules from the Cilia of
Tetrahymena Pyriformis. Journal of Cell Science, (5), 453-458.
Chaparro-Olaya J, Margos G, Coles DJ, Dluzewski AR, Mitchell GH, Wasserman MM,
Pinder JC. 2005. Plasmodium falciparum myosins: transcription and translation
during asexual parasite development. Cell Motil Cytoskel 60, 200-213.
Chen, Z.Y., Hasson, T., Kelley, P.M., Schwender, B.J., Schwartz, M.F., Ramakrishnan,
M., Kimberling, W.J., Mooseker M.S., and Corey, D.P. (1996). Molecular
cloning and domain structure of human myosin-VIIa, the gene product defective
in usher syndrome 1B. Genomics, 36(3), 440-448.
Cheney, R. E. and Mooseker M.S. (1992). Unconventional myosins. Current Opinion in
Cell Biology, 4(1), 27-35.
Chishti AH, Kim AC, Marfatia SM, Lutchman M, Hanspal M, Jindal H, Liu SC, Low
PS, Rouleau GA, Mohandas N, and others. 1998. The FERM domain: a unique
module involved in the linkage of cytoplasmic proteins to the membrane. Trends
Biochem Sci, 23, 281-282.
Chuang, C., Carpenter, A., Fuchsova, B., Johnson, T., deLanerolle, P., and Belmont, A.
(2006). Long-range directional movement of an interphase chromosome site.
Current Biology, 16(8), 825-831.
Cleffmann G. 1980. Chromatin elimination and the genetic organisation of the
macronucleus in Tetrahymena thermophila. Chromosoma. 78, 313-325.
Conboy, J., Kan Y.W., Shohet, S.B., Mohandas N. (1986). Molecular cloning of protein
4.1, a major structural element of the human erythrocyte membrane skeleton.
Proc Natl Acad Sci USA.,
Coluccio LM. 2008. Myosins: A Superfamily of Molecular Motors (Proteins and Cell
Regulation). New York: Springer, 469pp.

95

Correas I., Padilla R., and Avila J., (1990). The tubulin-binding sequence of brain
microtubule-associated proteins, tau and MAP-2, is also involved in actin binding.
Biochem J. 269(1), 61–64.
Coue, M., Brenner, S.L., Spector, I., Korn, E.D. (1987). Inhibition of actin
polymerization by latrunculin A. FEBS Letters 213(2), 316-318.
Diakowski, W. (2006). Protein 4.1, a component of the erythrocyte membrane skeleton
and its related homologue proteins forming the protein 4.1/FERM superfamily.
Folia Histochemica Et Cytobiologica, 44(4), 231-248.
Doberstein, S., and Pollard, T. (1992). Localization and specificity of the phospholipid
and actin binding sites on the tail of acanthamoeba myosin IC. The Journal of
Cell Biology, 117(6), 1241-1249.
Doll T., Meichsner M., Riederer B.M., Honegger P., and Matus A. (1993). An isoform of
microtubule-associated protein 2 (MAP2) containing four repeats of the tubulinbinding motif. Journal of Cell Science, 106( 2), 633-639.
Durbach A., Collins K., Matsudaira, R., Louvard, D., Coudrier, E. (1996). Brush border
myosin-I truncated in the motor domain impairs the distribution and the function
of endocytic compartments in an hepatoma cell line. Proc Natl Acad Sci USA
93(14) 7053-7058
Eisen, J.A., Coyne, R.S., Wu, M., Wu, D., Thiagarajan, M., Wortman, J.R., Badger, J.H.,
Ren, Q., Amedeo, P., Jones, K.M., Tallon, L.J., Delcher, A.L., Salzberg, S.L.,
Silva, J.C., Haas, B.J., Majoros, W.H., Farzad, M., Carlton, J.M., Smith, R.K. Jr.,
Garg, J., Pearlman, R.E., Karrer, K.M., Sun, L., Manning, G., Elde, N.C.,
Turkewitz, A.P., Asai, D.J., Wilkes, D.E., Wang, Y., Cai, H., Collins, K., Stewart,
B.A., Lee, S.R., Wilamowska, K., Weinberg, Z., Ruzzo, W.L., Wloga, D.,
Gaertig, J., Frankel, J., Tsao, C.C., Gorovsky, M.A., Keeling, P.J., Waller, R.F.,
Patron, N.J., Cherry, J.M., Stover, N.A., Krieger, C.J., del Toro, C., Ryder, H.F.,
Williamson, S.C., Barbeau, R.A., Hamilton, E.P., Orias, E. (2006). Macronuclear
genome sequence of the ciliate Tetrahymena thermophila, a model eukaryote.
PLoS biology. 4(9)

96

Elde, N. C., Morgan, G., Winey, M., Sperling, L. and Turkewitz, A. P. (2005).
Elucidation of clathrin-mediated endocytosis in tetrahymena reveals an
evolutionarily convergent recruitment of dynamin. PLoS Genet. 1(52), 524-522.
Engelhardt, V. A., and Lyubimowa, M. N. (1939). Myosin and adenosinetriphosphatase.
Nature, 144, 668-669.
Etournay, R., Zwaenepoel, I., Perfettini, I., Legrain, P., Petit, C., & El-Amraoui, A.
(2007). Shroom2, a myosin-VIIa- and actin-binding protein, directly interacts
with ZO-1 at tight junctions. Journal of Cell Science, 120(16), 2838-2850.
Flickinger, C. J. (1965). The fine structure of the nuclei of Tetrahymena pyriformis
throughout the cell cycle. The Journal of Cell Biology, 27(3), 519-529.
Finnerty CM, Chambers D, Ingraffea J, Faber HR, Karplus PA, Bretscher A. 2004. The
EBP50-moesin interaction involves a binding site regulated by direct masking on
the FERM domain. J Cell Sci. 117, 1547-1552.
Foth, B., Goedecke, M., and Soldati, D. (2006). From the cover: New insights into
myosin evolution and classification. Proc Natl Acad Sci., 103(10), 3681-3686.
Fujiu K, Numata, O. 2000 Reorganization of microtubules in the amitotically dividing
macronucleus of Tetrahymena. Cell Motil. Cytoskeleton, 46, 17-27.
Fukui, Y. (1989). Myosin I is located at the leading edges of locomoting Dictyostelium
amoebae. Nature, 341(6240), 328-331.
Gaertig, J., Gu, L., Hai, B., and Gorovsky M.A. (1994). High frequency vector-mediated
transformation and gene replacement in tetrahymena. Nucleic Acids Research, 22,
5391-5398.
Garces. J. A. & Gavin, R. H. 1996. Identification of a myosin heavy chain gene
(TETMYO-1 ) in Tetrahymena. Mol. Bio. Cell 7(37), 869-881.
Garcés, J. and Gavin R.H., (1998). A PCR screen identifies a novel, unconventional
myosin heavy chain gene (MYO1) in tetrahymena thermophila. The Journal of
Eukaryotic Microbiology, 45(3), 252-259.
Gavin, R. H. (1980). The oral apparatus of tetrahymena. V. oral apparatus polypeptides
and their distribution. Journal of Cell Science, 44(1), 317-333.
Gavin, R. H. (1997). Microtubule-Microfilament Synergy in the Cytoskeleton. In: Int Rev
Cytol, (173). New York, Academic Press. p. 207-242.
97

Gavin R.H. (1999) Synergy of cytoskeleton components. BioScience, 49(8), 641-655.
Gavin, R. H. (2001). Myosins in protists. In: Int Rev Cytol, (206). New York, Academic
Press. p. 97-134.
Gillespie, P., and Cyr, J. (2002). Calmodulin binding to recombinant myosin-1c and
myosin-1c IQ peptides. BMC Biochemistry 3(1), 31-48.
Gotesman M, Hosein RE, Gavin RH. 2010. A FERM domain in a class XIV myosin
interacts with actin and tubulin and localizes to the cytoskeleton, phagosomes,
and nucleus in Tetrahymena thermophila. Cytoskeleton 67:90-101.
Greider, C. W. (1985). Identification of a specific telomere terminal transferase activity
in Tetrahymena extracts. Cell, 43(2 Pt 1), 405-413.
Griffith L.M. and Pollard T.D. (1978). Evidence for actin filament-microtubule
interaction mediated by microtubule-associated proteins. JCB, (78), 958-965.
Guerra, C., Wada, Y., Leick, V., Bell, A., and Satir, P. (2003). Cloning, localization, and
axonemal function of tetrahymena centrin. Molecular Biology of the Cell, 14(1),
251-261.
Halliburton W.D., (1887). On muscle-plasma. J Physiol (8), 11-202.
Hamada K, Shimizu T, Matsui T, Tsukita S, Hakoshima T. 2000. Structural basis of the
membrane-targeting and unmasking mechanisms of the radixin FERM domain.
EMBO J. 19: 4449-4462.
Hamada K, Shimizu T, Yonemura S, Tsukita S, Tsukita S, Hakoshima T. 2003.
Structural basis of adhesion-molecule recognition by ERM proteins revealed by
the crystal structure of the radixin-ICAM-2 complex. EMBO J, 22, 502-514.
Hammonda JW, Caia D, Verhey KJ. 2008. Tubulin modifications and their cellular
functions. Curr Opin Cell Biol 20:71-76.
Hasson, T., Gillespie, P.G., Garcia, D.J.A., MacDonald, R.B., Zhao Y.D., Yee D.A.G.,
Mooseker M.S., Corey D.P. (1997). Unconventional myosins in inner-ear sensory
epithelia. The Journal of Cell Biology, 137(6), 1287-1307.
Hirono, M., Nakamura, M., Tsunemoto, M., Yasuda, T., Ohba, H., Numata, O. and
Watanabe, Y. (1987). Tetrahymena actin: Localization and possible biological
roles of actin in Tetrahymena cells. J. Biochem. 102, 537-545.

98

Hoffmann, E.K., Rasmussen, L., and Zeuthen, E. (1974). Cytochalasin B: Aspects of
Phagocytosis in Nutrient Uptake in Tetrahymena. J Cell Sci. 15, 403-406.
Hoey JG, Gavin RH. 1992. Localization of actin in the Tetrahymena basal body cage
complex. J Cell Sci ,103, 629-641.
Horowitz S, Gorovsky MA. 1985. An unusual genetic code in nunclear genes of
Tetrahymena. Proc Natl Acad Sci, 82, 2452-2455.
Hosein, R. E., Williams, S.A., and Gavin, R.H. (2005). Directed motility of phagosomes
in Tetrahymena thermophila requires actin and Myo1p, a novel unconventional
myosin. Cell Motility and the Cytoskeleton, 61(1), 49-60.
Hosein, R. E., and Gavin R.H. (2007). Myo1 localizes to phagosomes, some of which
traffic to the nucleus in a Myo1-dependent manner in Tetrahymena thermophila.
Cell Motility and the Cytoskeleton, 64(12), 926-937.
Huang, S., Jagadeeswaran, R., Liu, E. S., and Benz, E. J., Jr. (2004). Protein 4.1R, a
microtubule-associated protein involved in microtubule aster assembly in
mammalian mitotic extract. Journal of Biological Chemistry, 279(33), 3459534602.
Hulo N., Bairoch A., Bulliard V., Cerutti L., Cuche B., De Castro E., Lachaize C.,
Langendijk-Genevaux P.S., and Sigrist C.J.A. (2008). The 20 years of PROSITE.
Nucleic Acids Res. PS,=D245-D249.
Huxley, A. F. (1954). Structural changes in muscle during contraction interference
microscopy of living muscle fibres. Nature, 173(4412), 971-973.
Jacobs, M. E., DeSouza, L. V., Samaranayake, H., Pearlman, R. E., Siu, K. W. M., and
Klobutcher, L. A. (2006). The Tetrahymena thermophila phagosome proteome.
Eukaryotic Cell, 5(12), 1990-2000.
Katijama, Y., and Thompson, G.A. Jr., (1977). Differentiation of Food Vacuolar
Membranes During Endocytosis in Tetrahymena. Journal of Cell Biology, 75,
436-445.
Kiehart, D.P., Franke J.D., Chee M.K., Montague R.A., Chen T.L., Roote J., and
Ashburner M. (2004). Drosophila crinkled, Mutations of Which Disrupt
Morphogenesis and Cause Lethality, Encodes Fly Myosin VIIA. Genetics, 168,
1337-1352.
99

Kitano K, Yusa F, Hakoshim T. 2006. Structure of dimerized radixin FERM domain
suggests a novel masking motif in C-terminal residues 295–304. Acta Crystallogr
Sect F Struct Biol Cryst Commun., 62, 340–345.
Langford G.M. (1995). Actin- and microtubule-dependent organelle motors:
interrelationships between the two motility systems. Curr Opin Cell Biol. (1), 8288.
Lee HS, Bellin RM., Walke DL, Patel B, Powers P, Liu H, Garcia-Alvarez B, de Pereda
JM, Liddington RC, Volkmann N, Hanein D, Critchley DR, Robson, RM. 2004.
Characterization of an actin-binding site within the talin FERM domain. J. Mol
Biol 343, 771-784.
Lee, H. Bellin, R.B., Walker, D.L., Patel B., Powers, P., Liu, Garcia-Alverz, B., Pereda,
J.M.D., Liddington, R.C., Volkmann, N., Hamein, D., Critchley, D.R., and
Robson, M. (2004). Characterization of an actin-binding site within the talin
FERM domain. Journal of Molecular Biology, 343(3), 771-784.
Lee, W., Ostap, E. M., Zot, H. G., and Pollard, T. D. (1999). Organization and ligand
binding properties of the tail of acanthamoeba myosin-IA. Identification of an
actin-binding site in the basic (Tail Homology-1) domain. Journal of Biological
Chemistry, 274(49), 35159-35171.
Lengsfeld A.M., Löw, I., Wieland, T., Dancker, P., and Hasselbach W. (1974).
Interaction of Phalloidin with Actin. Proc Natl Acad Sci 71(7), 2803–2807.
Lewis S.A., Wang D.H., and Cowan N.J. (1988). Microtubule-associated protein MAP2
shares a microtubule binding motif with tau protein. Science 242(4880), 936-939
Li Q, Nance MR, Kulikauskas R, Nyberg K, Fehon R, Karplus PA, Bretscher A, Tesmer
JJ. 2006. Self-masking in an intact ERM-merlin protein: an active role for the
central alpha-helical domain. J Mol Biol., 365, 1446-1459.
Liu, R., Woolner, S., Johndrow, J. E., Metzger, D., Flores, A. and Parkhurst, S. M.
(2008). Sisyphus, the Drosophilamyosin XV homolog, traffics within filopodia
transporting key sensory and adhesion cargos. Development, 135, 53-63.
Lu, Q., and Henderson E. (2000). Two tetrahymena G-DNA-binding proteins, TGP1 and
TGP3, share novel motifs and may play a role in micronuclear division. Nucleic
Acids Research, 28(15), 2993-3001.
100

Lymn, R.W., and Taylor E.W. (1971). Mechanism of adenosine triphosphate hydrolysis
by actomyosin. Biochemistry, 10(25), 4617-4624.
Mattagajasingh, S.N., Huang, S.C., Hartenstein, J.S., and Benz E.J. (2000).
Characterization of the interaction between protein 4.1 R and ZO-2. A possible
link between the tight junction and the actin cytoskeleton. The Journal of Biological
Chemistry, 275(39), 30573-30585.
McNeil, E. L., Tacelosky, D., Basciano, P., Biallas, B., Williams, R., Damiani, P.,
Deacon, S., Fox, C., Stewart, B., Petruzzi, N., Osborn, C., Klinger, K., Sellers, J.
R., and Smith, C. K. (2004) Cell Motil. Cytoskeleton, 58, 71-82
Muranen T., Grönholm M., Lampin A., Lallemand D., Zhao F., Giovannini M., and
Carpén O. (2007). The tumor suppressor merlin interacts with microtubules and
modulates Schwann cell microtubule cytoskeleton. Hum Mol Genet., 16(14),
1742-1751.
Nanney, D. L., and McCoy, J.W. Characterization of the Species of the Tetrahymena
pyriformis Complex. Transactions of the American Microscopical Society, 95(4)
664-682
Narasimhulu, S. B. (1998). Characterization of microtubule binding domains in the
Arabidopsis kinesin-like calmodulin binding protein. The Plant Cell, 10(6), 957-966.
Niggli V, Andreoli C, Roy C, Mangeat P. 1995. Identification of a phosphatidylinositol4,5-bisphosphate-binding domain in the N-terminal region of ezrin. FEBS Lett.,
376, 172-176.
Nilsson, J.R., Van Deurs, B. (1983). Coated pits and pinocytosis in Tetrahymena. J Cell
Sci. 63, 209– 222
Ng S.F., (1978). Directionality of microtubule assembly: an in vivo study with the ciliate
Tetrahymena. J Cell Sci 33(1), 227-234
Numata O., Fujiu K., and Gonda K. (1999). Macronuclear division and cytokinesis in
Tetrahymena. Cell Biology International, 23(12), 849-857.
Odronitz F. and Kollmar M. (2007). Drawing the tree of eukaryotic life based on the
analysis of 2,260 manually annotated myosins from 328 species. Genome
Biology, 8 (9). 10.1186/gb-2007-8-9-r196

101

Orias, E. (1991). On the evolution of the karyorelict ciliate life cycle: Heterophasic
ciliates and the origin of ciliate binary fission. Bio Systems, 25(1-2), 67-73.
Orias E. Flacks M. 1975. Macronuclear genetics of Tetrahymena. I. Random distribution
of macronuclear genecopies in Tetrahymena pyriformis syngen 1. Genetics, 79,
187-206.
Orias E, Hamilton EP, Orias J. 2000. Tetrahymena as a laboratory organism: Useful
strains, cell culture, and cell line maintenance. In: Asai DJ, Forney JD, editors.
Methods in Cell Biology: Tetrahymena thermophila. New York: Academic Press
62: 189-211.
Percipalle P, Fomproix N, Cavellán E, Voit R, Reimer G, Krüger T, Thyberg J, Scheer U,
Grummt I, Farrants AK. 2006. The chromatin remodelling complex WSTFSNF2h interacts with nuclear myosin 1 and has a role in RNA polymerase I
transcription. EMBO Rep. 5:525-30
Pearson M.A., Reczek D., Bretscher A., and Karplus P.A. (2000). Structure of the ERM
protein moesin reveals the FERM domain fold masked by an extended actin
binding tail domain. Cell., 101(3), 259-270
Pérez-Ferreiro, C. M. (2006). Protein 4.1R self-association: Identification of the binding
domain. The Biochemical Journal, 400(3), 457.
Philimonenko VV, Janácek J, Harata M, Hozák P. (2010). Transcription-dependent
rearrangements of actin and nuclear myosin I in the nucleolus. Histochem Cell
Biol. 134(3):243-9
Pollard, T. D., and Korn, E. D. (1973). Acanthamoeba myosin. I. Isolation from
Acanthamoeba castellanii of an enzyme similar to muscle. Journal of Biological
Chemistry, 248(13), 4682-4690.
Pollenz, R. S. (1992). The dictyostelium essential light chain is required for myosin
function. Cell, 69(6), 951-962.
Pranchevicius MC, Baqui MM, Ishikawa-Ankerhold HC, Lourenço EV, Leão RM, Banzi
SR, dos Santos CT, Roque-Barreira MC, Espreafico EM, Larson RE. (2008).
Myosin Va phosphorylated on Ser1650 is found in nuclear speckles and
redistributes to nucleoli upon inhibition of transcription. CMC. 65(6): 441-56.

102

Rannestad J., and Williams N.E., The synthesis of microtubules and other proteins of the
oral apparatus in Tetrahymena pyriformis. JCB 50, 709-720,
Rahaman A, Elde NC, Turkewitz AP. 2008. A dynamin-related protein required for
nuclear remodeling in Tetrahymena. Curr Biol., 18, 1227-1233.
Rasmussen, L., and Orias, E. (1975). Tetrahymena: Growth Without Phagocytosis.
Science, 190(4213), 464-465.
Rhoads, A.R., Friedberg, F. (1997). Sequence motifs for calmodulin recognition. The
FASEB Journal, 11(5), 331-340.
Richards, T.A. and Cavalier-Smith, T. (2005). Myosin domain evolution and the primary
divergence of eukaryotes. Nature, 436(7054), 1113-1118.
Reddy, V.S., and Reddy A.S., (1999). A plant calmodulin-binding motor is part kinesin
and part myosin. Bioinformatics, 15(12), 1055-1057.
Saitoh A, Takiguchi K, Tanaka Y, Hotani H. 1998. Opening-up of liposomal membranes
by talin. Proc Natl Acad Sci USA 95, 1026-1031.
Salerno VP, Calliari A, Provance DW Jr, Sotelo-Silveira JR, Sotelo JR, Mercer JA.
(2008). Myosin-Va mediates RNA distribution in primary fibroblasts from
multiple organs. CMC. 65(5):422-33.
Sandquist, J.C., Bement, W., (2010). Characterizing the Role of Myosin-10 in Regulating
Mitotic Spindle Structure and Function. Mol. Biol. Cell 21 (suppl), Abstract B
1263.
Sandquist, J.C., Woolner, s., Bement, W., (2009). Characterization of a Novel Interaction
between Myosin-10 and a Mitotic Kinase. Mol. Biol. Cell 20 (suppl), Abstract B
513.
Shearer, A.E., Hildebrand, M.S., Webster, J.A., Kahrizi, K., Meyer, N.C., Jalalvand, K.,
Arzhanginy, S.,Kimberling, W.J., Stephan, D., Bahlo, M., Smith, R.J. and
Najmabadi, H. 2009. Mutations in the first MyTH4 domain of MYO15A are a
common cause of DFNB3 hearing loss. Laryngoscope 119, 727-733.
Stattilaro R.F., Dentler W.L., and LeCluyse E.L. (1981). Microtubule-associated proteins
(MAPs) and the organization of actin filaments in vitro. JCB, (90), 467-473.

103

Schwander M, Lopes V, Sczaniecka A, Gibbs D, Lillo C, Delano D, Tarantino LM,
Wiltshire T, Williams DS, Müller U. (2009). A novel allele of myosin VIIa
reveals a critical function for the C-terminal FERM domain for melanosome
transport in retinal pigment epithelial cells. J Neurosci. 29(50):15810-8.
Straub, F.B. (1942). Actin. Stud. Inst. Med. Chem. Univ. Szeged. II:3–15.
Straub, F.B. (1943). Actin, II. Stud. Inst. Med. Chem. Univ. Szeged. III:23–37.
Shang, Y., Song, X., Bowen, J., Corstanje, R., Gao, Y., Gaertig, J., Gorovsky M.A.
(2002). A robust inducible-repressible promoter greatly facilitates gene
knockouts, conditional expression, and overexpression of homologous and
heterologous genes in Tetrahymena thermophila. PNAS, 99(6), 3734-3739.
Shimizu T., Seto A., Maita N., Hamada K., Tsukita S., Tsukita S., and Hakoshima T.
(2002). Structural basis for neurofibromatosis type 2. Crystal structure of the
merlin FERM domain. J Biol Chem. 277(12):10332-10336
Smith JS, Yakisich JS, Kapler GM, Cole ES, Romero P. 2004. A ß-Tubulin mutation
selectively uncouples nuclear division and cytokinesis in Tetrahymena
thermophila. Eukaryot. Cell, 3, 1217-1226.
Spudich J.A., Lin S., (1973). Cytochalasin B, Its Interaction with Actin and Actomyosin
from Muscle. Proc Natl Acad Sci., 9(2), 442–446.
Stuart KS, Cole, ES 2000. Nuclear and cytoskeletal fluorescence microscopy techniques.
In: Asai, DJ, Forney JD, editors. Methods in Cell Biology: Tetrahymena
thermophila. New York: Academic Press 62: 291-311.
Sugita, M., Nakano, K., Sato, M., Toyooka, K. and Numata, O. (2009) The roles of actin
cytoskeleton and microtubules for membrane recycling of a food vacuole in
Tetrahymena thermophila. Cell Motil Cytoskeleton, 66: 371-377.
Takeda S, Saitoh A, Furuta M, Satomi N, Ishino A, Nishida G, Sudo H, Hotani H,
Takiguchi K. 2006. Opening of holes in liposomal membranes is induced by
proteins possessing the FERM domain. J Mol Biol. 362:403-413
Titus MA. 2003. An unconventional myosin essential for the initiation of Dictyostelium
development. Mol Biol Cell 14:S, 181a.

104

Todi, S.V., Sivan-Loukianova, E., Jacobs J.S., Kiehart, D.P., and Eberl, D.F. (2008).
Myosin VIIA, important for human auditory function, is necessary for drosophila
auditory organ development. PloS One, 3(5) :e2115.
Tondravi M.M., and Yao M.C., (1986). Transformation of Tetrahymena thermophila by
microinjection of ribosomal RNA genes. PNAS 83, 4369-4373.
Tuxworth, R. I., Stephens, S., Ryan, Z. C., and Titus, M. A. (2005). Identification of a
myosin VII-talin complex. Journal of Biological Chemistry, 280(28), 2655726564.
Wang A, Liang Y, Fridell RA, Probst FJ, Wilcox ER, Touchman JW, Morton CC, Morell
RJ, Noben-Trauth K, Camper SA, Friedman TB.1998. Association of
unconventional myosin MYO15 mutations with human nonsyndromic deafness
DFNB3. Science, 280, 1447-1451.
Weber, K. L. (2004). A microtubule-binding myosin required for nuclear anchoring and
spindle assembly. Nature, 431(7006), 325-329.
Weil D, Blanchard S, Kaplan J, Guilford P, Gibson F, Walsh J, Mburu P, Varela A,
Levilliers J, Weston MD, et al. 1995. Defective myosin VIIA gene responsible for
Usher syndrome type 1B. Nature, 374, 60-61.
Williams NE. 2000. Immunoprecipitation Procedures. In: Asai DJ, Forney JD, editors.
Methods in Cell Biology: Tetrahymena thermophila. New York: Academic Press
62:449-453
Williams, N., and Williams, R. (1976). Macronuclear division with and without
microtubules in tetrahymena. Journal of Cell Science, 20(1), 61-77.
Williams, N.E., Tsao, C.C., Bowen, J., Hehman, G.L., Williams R.J., and Frankel J.
(2006). The Actin Gene ACT1 Is Required for Phagocytosis, Motility, and Cell
Separation of Tetrahymena thermophila. Eukaryotic Cell 5(3), 555-567.
Williams, S. A., Hosein R.E. and Gavin R.H. (2000). MYO1, a novel, unconventional
myosin gene affects endocytosis and macronuclear elongation in tetrahymena
thermophila. The Journal of Eukaryotic Microbiology, 47(6), 561-568.
Williams, S. A., and Gavin, R.H. (2005). Myosin genes in tetrahymena. Cell Motility and
the Cytoskeleton, 61(4), 237-243.

105

Wloga D, Rogowski K, Sharma N, Van Dijk J, Janke C, Eddé B, Bré MH, Levilliers N,
Redeker V, Duan J, Gorovsky MA, Jerka-Dziadosz M, Gaertig J. 2008.
Glutamylation on alpha-tubulin is not essential but affects the assembly and
functions of a subset of microtubules in Tetrahymena thermophila. Eukaryot Cell
7, 1362-1372.
Wolfrum, U., Liu, X., Schmitt, A., Udovichenko, I.P., Williams, D.S. (1998). Myosin
VIIa as a common component of cilia and microvilli. Cell Motility and the
Cytoskeleton, 40(3), 261-271.
Woods G., and Zito K. (2008). Preparation of Gene Gun Bullets and Biolistic
Transfection of Neurons in Slice Culture. JoVE. 12.
http://www.jove.com/index/Details.stp?ID=675, doi: 10.3791/675
Xu, H. and Gutman, D. H. (1998) Merlin differentially associates with the microtubule
and actin cytoskeleton. J. Neurosci. Res. 51, 403–415
Xu, P., Mitchelhill, K. I., Kobe, B., Kemp, B. E., and Zot, H. G. (1997). The myosin-I
binding protein Acan125 binds the SH3 domain and belongs to the superfamily
of leucine-rich repeat proteins. PNAS, 94(8), 3685-3690.
Yan, B., Calderwood, D. A., Yaspan, B., and Ginsberg, M. H. (2001). Calpain cleavage
promotes talin binding to the beta 3 integrin cytoplasmic domain. Journal of
Biological Chemistry, 276(30), 28164-28170.
Yang Y, Baboolal TG, Siththanandan V, Chen M, Walker ML, Knight PJ, Peckham M,
Sellers JR. 2009. A FERM domain autoregulates Drosophila myosin 7a activity.
Proc Natl Acad Sci USA 106, 4189-4194.
Yao, M. C. (1986). Amplification of Ribosomal RNA genes. In: Gall, L. G. (ed.), The
Molecular Biology of Ciliated Protozoa. Academic Press, Orlando. p. 179-201.
Yonezawa, S., Yoshizaki, N., Sano, M., Hanai, A., Masaki, S., Takizawa, T., Kageyama,
T., Moriyama, A. (2003). Possible involvement of myosin-X in intercellular
adhesion: Importance of serial pleckstrin homology regions for intracellular
localization. Development, Growth Differentiation, 45(2), 175-185.

106

Yumura, S., and Uyeda, T.Q. (1997). Transport of myosin II to the equatorial region
without its own motor activity in mitotic Dictyostelium cells. Molecular Biology of
the Cell, 8(10), 20890-2099.
Zaug, A., and Cech, T. (1986). The intervening sequence RNA of tetrahymena is an
enzyme. Science, 231(4737), 470-475.
Zhang H, Berg JS, Li Z, Wang Y, Lang P, Sousa AD, Bhaskar A, Cheney RE, Stromblad
S. 2004. Myosin-X provides a motor-based link between integrins and the
cytoskeleton. Nat Cell Biol., 6, 523-531.

107

